05.07.2014 Views

Opting out of Statutory Health Insurance in Germany and the ... - SFI

Opting out of Statutory Health Insurance in Germany and the ... - SFI

Opting out of Statutory Health Insurance in Germany and the ... - SFI

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

FIRST DRAFT ONLY – PLEASE DO NOT CITE<br />

<strong>Opt<strong>in</strong>g</strong> <strong>out</strong> <strong>of</strong> statutory health <strong>in</strong>surance: <strong>the</strong> case <strong>of</strong> <strong>Germany</strong><br />

<strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

Sarah Thomson* <strong>and</strong> Elias Mossialos**<br />

* Research Officer, European Observatory on <strong>Health</strong> Care Systems <strong>and</strong> Research Officer <strong>in</strong><br />

<strong>Health</strong> Policy, LSE <strong>Health</strong> <strong>and</strong> Social Care (correspond<strong>in</strong>g author)<br />

** Reader <strong>in</strong> <strong>Health</strong> Policy, Department <strong>of</strong> Social Policy, LSE <strong>and</strong> Co-Director <strong>of</strong> LSE <strong>Health</strong><br />

<strong>and</strong> Social Care<br />

Acknowledgements<br />

The authors are grateful to Annemarie Ter L<strong>in</strong>den <strong>and</strong> Marieke Datema for <strong>the</strong>ir assistance<br />

with documents <strong>in</strong> Dutch <strong>and</strong> German.<br />

Address for correspondence:<br />

Sarah Thomson<br />

J301, LSE <strong>Health</strong> <strong>and</strong> Social Care, LSE, Houghton Street, London WC2 2AE<br />

Email: s.thomson@lse.ac.uk<br />

Tel: +44-20-7955-6474 / Fax: +44-20-7955-6803


<strong>Opt<strong>in</strong>g</strong> <strong>out</strong> <strong>of</strong> statutory health <strong>in</strong>surance: <strong>the</strong> case <strong>of</strong> <strong>Germany</strong><br />

<strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

Introduction<br />

People liv<strong>in</strong>g <strong>in</strong> <strong>the</strong> European Union (EU) rarely purchase private or voluntary health<br />

<strong>in</strong>surance (VHI) as a substitute for health <strong>in</strong>surance provided by <strong>the</strong> state. This is because<br />

statutory health <strong>in</strong>surance usually covers <strong>the</strong> whole population. Exceptions to this trend are<br />

only found <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, where levels <strong>of</strong> statutory health <strong>in</strong>surance<br />

coverage are as low as 92.2 <strong>and</strong> 75.6 per cent respectively (Organisation for Economic Cooperation<br />

<strong>and</strong> Development 2002).<br />

Unlike o<strong>the</strong>r EU member states, governments <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s exclude a<br />

significant proportion <strong>of</strong> <strong>the</strong> population from – or allow specific groups <strong>of</strong> people to opt <strong>out</strong> <strong>of</strong> –<br />

<strong>the</strong> statutory health <strong>in</strong>surance scheme. Those who are excluded from statutory coverage can<br />

purchase ‘substitutive’ VHI from private health <strong>in</strong>surers if <strong>the</strong>y require protection from <strong>the</strong><br />

f<strong>in</strong>ancial consequences <strong>of</strong> ill health. Those who are permitted to opt <strong>out</strong> can choose between<br />

statutory <strong>and</strong> substitutive VHI coverage; opt<strong>in</strong>g for <strong>the</strong> latter exempts <strong>the</strong>m from mak<strong>in</strong>g<br />

f<strong>in</strong>ancial contributions to <strong>the</strong> statutory health <strong>in</strong>surance scheme i .<br />

It is <strong>of</strong>ten argued that governments <strong>in</strong> o<strong>the</strong>r European countries should adopt <strong>the</strong> German or<br />

Dutch model <strong>and</strong> exclude people from or allow <strong>the</strong>m to opt <strong>out</strong> <strong>of</strong> some or all aspects <strong>of</strong> <strong>the</strong><br />

statutory health <strong>in</strong>surance scheme (Blackwell <strong>and</strong> Kruger 2002; Howard 2003). At <strong>the</strong> time <strong>of</strong><br />

writ<strong>in</strong>g, for example, <strong>the</strong> Italian, Slovakian <strong>and</strong> Russian governments are seriously<br />

consider<strong>in</strong>g <strong>the</strong> <strong>in</strong>troduction <strong>of</strong> an opt <strong>out</strong> policy.<br />

Two assumptions underlie arguments <strong>in</strong> favour <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies. First, that<br />

public resources for health care are limited <strong>and</strong> overstretched. If more people, particularly<br />

those with higher <strong>in</strong>comes, are given <strong>the</strong> opportunity or compelled to take f<strong>in</strong>ancial<br />

responsibility for <strong>the</strong>ir own health protection, public expenditure on health care will fall, relative<br />

to private expenditure, <strong>and</strong> <strong>the</strong> government will be able to devote a larger share <strong>of</strong> its<br />

resources to provid<strong>in</strong>g health care for poorer people. Second, that <strong>in</strong>creased choice for<br />

consumers <strong>and</strong> <strong>the</strong> threat <strong>of</strong> voluntary exit from <strong>the</strong> statutory health <strong>in</strong>surance scheme will<br />

stimulate competition between statutory <strong>and</strong> private health <strong>in</strong>surers, lead<strong>in</strong>g to efficiency<br />

ga<strong>in</strong>s <strong>and</strong> improved quality <strong>in</strong> <strong>the</strong> health system as a whole.<br />

1


In practice, however, exclusion <strong>and</strong> opt <strong>out</strong> policies are not as straightforward as <strong>the</strong>y at first<br />

appear to be. They may also conflict with health system objectives. Due to differences <strong>in</strong> <strong>the</strong><br />

way <strong>in</strong> which statutory <strong>and</strong> private health <strong>in</strong>surers operate, <strong>the</strong> possibility <strong>of</strong> voluntary exit<br />

from <strong>the</strong> statutory health <strong>in</strong>surance scheme is likely to threaten its f<strong>in</strong>ancial stability: private<br />

health <strong>in</strong>surers are able to attract younger <strong>and</strong> healthier people, leav<strong>in</strong>g <strong>the</strong> state to cover an<br />

adverse selection <strong>of</strong> older people <strong>and</strong> people <strong>in</strong> poor health. As a result <strong>of</strong> <strong>the</strong> correlation<br />

between health status, age <strong>and</strong> <strong>in</strong>come, a similar situation may arise when higher <strong>in</strong>come<br />

people are excluded from statutory coverage. In ei<strong>the</strong>r case, <strong>the</strong> burden <strong>of</strong> rais<strong>in</strong>g revenue to<br />

fund <strong>the</strong> statutory health <strong>in</strong>surance scheme will fall disproportionately on people with lower<br />

<strong>in</strong>comes <strong>and</strong> lower levels <strong>of</strong> health, unless this revenue is subsidised through taxation or<br />

m<strong>and</strong>atory contributions from those covered by substitutive VHI. Exclusion <strong>and</strong> opt <strong>out</strong><br />

policies may <strong>the</strong>refore underm<strong>in</strong>e levels <strong>of</strong> solidarity between those with high <strong>and</strong> low<br />

<strong>in</strong>comes <strong>and</strong> between those at high <strong>and</strong> low risk <strong>of</strong> ill health.<br />

A fur<strong>the</strong>r issue concerns <strong>the</strong> behaviour or conduct <strong>of</strong> <strong>in</strong>surers <strong>in</strong> a market for private health<br />

<strong>in</strong>surance. Private health <strong>in</strong>surers generally operate <strong>in</strong> an environment that gives <strong>the</strong>m<br />

considerable freedom from government <strong>in</strong>tervention, relative to statutory <strong>in</strong>surers. It could be<br />

argued that this freedom is a necessary pre-requisite for <strong>the</strong> smooth function<strong>in</strong>g <strong>of</strong> a<br />

competitive market. However, private health <strong>in</strong>surance is characterised by a number <strong>of</strong><br />

market failures, so unless it is subject to some degree <strong>of</strong> regulation, it is likely to be an<br />

<strong>in</strong>efficient <strong>and</strong> <strong>in</strong>equitable means <strong>of</strong> fund<strong>in</strong>g health care (Barr 1992). Certa<strong>in</strong> aspects <strong>of</strong><br />

market conduct may restrict choice for some consumers, particularly older people <strong>and</strong> people<br />

<strong>in</strong> poor health, <strong>and</strong> prevent <strong>the</strong>m from obta<strong>in</strong><strong>in</strong>g an affordable <strong>and</strong> adequate level <strong>of</strong><br />

substitutive VHI cover. This is <strong>of</strong> particular importance <strong>in</strong> <strong>the</strong> context <strong>of</strong> a market for<br />

substitutive VHI, given its role <strong>in</strong> provid<strong>in</strong>g people with protection from <strong>the</strong> f<strong>in</strong>ancial<br />

consequences <strong>of</strong> ill health.<br />

This paper reviews <strong>the</strong> operation <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>in</strong> <strong>the</strong> health sector <strong>in</strong><br />

<strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong> only European countries <strong>in</strong> which such policies affect a<br />

significant proportion (more than one per cent) <strong>of</strong> <strong>the</strong> population. In do<strong>in</strong>g so it aims to<br />

illustrate <strong>the</strong> potential impact <strong>of</strong> <strong>in</strong>troduc<strong>in</strong>g exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>in</strong> European health<br />

systems <strong>and</strong> to highlight <strong>the</strong> consequences <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies for specific<br />

health system objectives.<br />

After <strong>out</strong>l<strong>in</strong><strong>in</strong>g <strong>the</strong> relationship between statutory <strong>and</strong> substitutive VHI coverage <strong>in</strong> <strong>Germany</strong><br />

<strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong> paper reviews <strong>the</strong> consequences <strong>of</strong> allow<strong>in</strong>g some people to choose<br />

between statutory <strong>and</strong> substitutive VHI coverage <strong>and</strong> exam<strong>in</strong>es <strong>the</strong> implications <strong>of</strong> <strong>the</strong> way <strong>in</strong><br />

which private health <strong>in</strong>surers behave <strong>in</strong> a market for substitutive VHI. The paper’s central<br />

argument is that exclusion <strong>and</strong> opt <strong>out</strong> policies do not live up to <strong>the</strong> expectation that <strong>the</strong>y will<br />

stimulate competition between statutory <strong>and</strong> voluntary health <strong>in</strong>surance, nor are <strong>the</strong>y likely to<br />

2


enable governments to conserve public resources for <strong>the</strong> benefit <strong>of</strong> poorer people. Ra<strong>the</strong>r,<br />

<strong>the</strong>se policies conflict with <strong>the</strong> health system objectives <strong>of</strong> equity <strong>in</strong> fund<strong>in</strong>g health care, equity<br />

<strong>of</strong> access to health care, efficiency <strong>and</strong> choice. They also create complexities that precipitate<br />

high levels <strong>of</strong> government <strong>in</strong>tervention <strong>in</strong> areas traditionally free from significant state control.<br />

<strong>Statutory</strong> <strong>and</strong> voluntary health <strong>in</strong>surance <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

The orig<strong>in</strong>s <strong>of</strong> choice between statutory <strong>and</strong> substitutive VHI coverage <strong>in</strong> <strong>Germany</strong> date back<br />

to <strong>the</strong> establishment <strong>of</strong> compulsory health <strong>in</strong>surance at <strong>the</strong> end <strong>of</strong> <strong>the</strong> n<strong>in</strong>eteenth century. In<br />

1881 <strong>the</strong> chancellor Bismarck attempted to enact legislation for a universal scheme <strong>of</strong><br />

compulsory health <strong>in</strong>surance, but due to heavy political opposition from Liberals <strong>and</strong> Social<br />

Democrats, <strong>the</strong> provisions <strong>of</strong> <strong>the</strong> act that came <strong>in</strong>to force <strong>in</strong> 1883 only established compulsory<br />

enrolment for blue collar workers (Alber 1986; Rosenberg 1986; Katzenste<strong>in</strong> 1987). In 1970 a<br />

new law made enrolment <strong>in</strong> <strong>the</strong> statutory health <strong>in</strong>surance scheme (Gesetzliche<br />

Krankenversicherung; GKV) compulsory for white collar workers with earn<strong>in</strong>gs below an<br />

<strong>in</strong>come threshold (see Table 1). The law also allowed white collar workers with earn<strong>in</strong>gs<br />

above <strong>the</strong> threshold to enrol <strong>in</strong> <strong>the</strong> GKV on a voluntary basis, <strong>the</strong>reby establish<strong>in</strong>g choice<br />

between statutory <strong>and</strong> substitutive VHI coverage for this group. S<strong>in</strong>ce a fur<strong>the</strong>r legislative<br />

change <strong>in</strong> 1989, any employee with earn<strong>in</strong>gs below <strong>the</strong> <strong>in</strong>come threshold, with <strong>the</strong> exception<br />

<strong>of</strong> public sector workers, is compulsorily enrolled <strong>in</strong> <strong>the</strong> GKV, while all those with earn<strong>in</strong>gs<br />

above <strong>the</strong> threshold are permitted to enrol <strong>in</strong> <strong>the</strong> GKV if <strong>the</strong>y so wish.<br />

Employers now <strong>in</strong>form employees when <strong>the</strong>ir gross annual earn<strong>in</strong>gs rise above <strong>the</strong> <strong>in</strong>come<br />

threshold (€45,900 <strong>in</strong> 2003) <strong>and</strong> present <strong>the</strong>m with three options: <strong>the</strong>y can choose not to be<br />

covered by any type <strong>of</strong> health <strong>in</strong>surance; <strong>the</strong>y can purchase substitutive VHI; or <strong>the</strong>y can rejo<strong>in</strong><br />

<strong>the</strong> GKV as voluntary enrolees (Busse 2000). Employees with earn<strong>in</strong>gs above <strong>the</strong> <strong>in</strong>come<br />

threshold <strong>and</strong> <strong>the</strong>ir dependants account for ab<strong>out</strong> 20 per cent <strong>of</strong> <strong>the</strong> population. Three<br />

quarters <strong>of</strong> <strong>the</strong>m choose to rema<strong>in</strong> <strong>in</strong> <strong>the</strong> GKV as voluntary members. The rema<strong>in</strong>der (ab<strong>out</strong><br />

4.5 per cent <strong>of</strong> <strong>the</strong> population) choose to purchase substitutive VHI from one <strong>of</strong> 50 private<br />

health <strong>in</strong>surance companies belong<strong>in</strong>g to <strong>the</strong> German Association <strong>of</strong> Private <strong>Health</strong> Insurers<br />

(Verb<strong>and</strong> der privaten Krankenversicherung; PKV) (PKV 2001). A very small group (0.2 per<br />

cent <strong>of</strong> <strong>the</strong> population) has no health <strong>in</strong>surance coverage at all – ma<strong>in</strong>ly extremely wealthy<br />

people (Busse 2002).<br />

Prior to <strong>the</strong> second world war statutory health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s was entirely<br />

voluntary. A compulsory scheme was established <strong>in</strong> 1941, at <strong>the</strong> <strong>in</strong>stigation <strong>of</strong> <strong>the</strong> occupy<strong>in</strong>g<br />

German forces <strong>and</strong> with disregard for <strong>the</strong> exist<strong>in</strong>g <strong>in</strong>stitutional structures (Blanpa<strong>in</strong> et al. 1978;<br />

3


Cox 1993). The 1941 legislation was largely based on <strong>the</strong> German system, divid<strong>in</strong>g statutory<br />

health <strong>in</strong>surance <strong>in</strong>to two sections: compulsory enrolment for employees <strong>and</strong> <strong>the</strong>ir<br />

dependants <strong>and</strong> voluntary enrolment for self-employed people. The rema<strong>in</strong>der were expected<br />

to purchase private health <strong>in</strong>surance on a voluntary basis. Between 1941 <strong>and</strong> 1965 statutory<br />

coverage was extended to new groups <strong>of</strong> non-employed people. The 1964 Sickness Funds<br />

Act (Ziekenfondswet; ZFW) came <strong>in</strong>to force <strong>in</strong> 1966, establish<strong>in</strong>g <strong>the</strong> system that is <strong>in</strong> place<br />

today. S<strong>in</strong>ce 1966, ab<strong>out</strong> three quarters <strong>of</strong> <strong>the</strong> Dutch population have been covered by <strong>the</strong><br />

ZFW (Organisation for Economic Co-operation <strong>and</strong> Development 2001).<br />

<strong>Health</strong> <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s currently operates on three levels (see Table 2) (M<strong>in</strong>istry<br />

<strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport 2002). The first level provides cover for long-term care. Based on<br />

<strong>the</strong> 1967 Exceptional Medical Expenses Act (Algemene Wet Bijzondere Ziektekosten;<br />

AWBZ), it is a universal scheme that is compulsory for all residents.<br />

The second level provides compulsory cover for ‘normal necessary care’, under <strong>the</strong> ZFW, to<br />

employees up to <strong>the</strong> age <strong>of</strong> 65 with gross annual earn<strong>in</strong>gs under <strong>the</strong> <strong>in</strong>come threshold,<br />

residents on benefits <strong>and</strong> (s<strong>in</strong>ce 2000) self-employed people under <strong>the</strong> age <strong>of</strong> 65 with taxable<br />

<strong>in</strong>comes below a lower threshold (see Table 1) (M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport 2002). It<br />

also provides cover on a voluntary basis for members who reach <strong>the</strong> age <strong>of</strong> 65 <strong>and</strong> nonmembers<br />

who are 65 <strong>and</strong> over <strong>and</strong> have a gross annual <strong>in</strong>come below <strong>the</strong> lower threshold.<br />

Individuals with gross annual earn<strong>in</strong>gs above <strong>the</strong> <strong>in</strong>come threshold are no longer eligible for<br />

ZFW coverage, but may purchase substitutive VHI <strong>in</strong>stead. Some civil servants are also<br />

excluded from <strong>the</strong> ZFW. They are covered by a separate statutory health <strong>in</strong>surance scheme<br />

(Publiekrechtelijke ziektekostenverzeker<strong>in</strong>g; PZV), which closely resembles <strong>the</strong> ZFW.<br />

Those that are not eligible for cover under <strong>the</strong> ZFW can purchase substitutive VHI or be<br />

un<strong>in</strong>sured. In 2000 24.7 per cent <strong>of</strong> <strong>the</strong> Dutch population purchased substitutive VHI, down<br />

from 27.2 per cent <strong>in</strong> 1990 (Vektis 2000). Only 1.6 per cent <strong>of</strong> <strong>the</strong> population did not have any<br />

health <strong>in</strong>surance at all; most <strong>of</strong> <strong>the</strong> un<strong>in</strong>sured are homeless <strong>and</strong> a few conscientiously object<br />

to <strong>in</strong>surance (M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport 2000). The <strong>Health</strong> <strong>Insurance</strong> Access Act<br />

(Wet op de Toegang tot Ziektekostenverzeker<strong>in</strong>gen; WTZ) passed <strong>in</strong> 1986 guarantees<br />

substitutive VHI policy holders aged 65 <strong>and</strong> over access to a ‘st<strong>and</strong>ard’ policy that provides a<br />

similar level <strong>of</strong> benefits to <strong>the</strong> ZFW for a fixed premium (see below).<br />

Level three consists <strong>of</strong> complementary <strong>and</strong> supplementary VHI, which can be purchased by<br />

anyone, on a voluntary basis, from sickness funds <strong>and</strong> private <strong>in</strong>surers.<br />

Insert Table 1 here<br />

Insert Table 2 here<br />

4


The health <strong>in</strong>surance options available to different population groups <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s are presented <strong>in</strong> Table 3. In both countries <strong>the</strong> size <strong>of</strong> <strong>the</strong> market for substitutive<br />

VHI is sensitive to developments <strong>in</strong> <strong>the</strong> statutory health <strong>in</strong>surance scheme. Changes <strong>in</strong> <strong>the</strong><br />

benefits provided by statutory coverage are usually followed by changes <strong>in</strong> <strong>the</strong> benefits<br />

provided by substitutive VHI.<br />

Insert Table 3 here<br />

Issues aris<strong>in</strong>g from <strong>the</strong> choice between statutory <strong>and</strong> voluntary health<br />

<strong>in</strong>surance<br />

Allow<strong>in</strong>g certa<strong>in</strong> groups <strong>of</strong> people to opt <strong>out</strong> <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance scheme<br />

presents private health <strong>in</strong>surers with strong <strong>in</strong>centives to persuade low risk <strong>in</strong>dividuals to<br />

leave <strong>the</strong> statutory health <strong>in</strong>surance scheme <strong>and</strong> purchase substitutive VHI. This form <strong>of</strong> risk<br />

selection is made possible by differences <strong>in</strong> <strong>the</strong> way <strong>in</strong> which statutory <strong>and</strong> private health<br />

<strong>in</strong>surers operate, particularly with regard to enrolment, premium-sett<strong>in</strong>g <strong>and</strong> policy conditions.<br />

Those who can obta<strong>in</strong> cheaper coverage from private health <strong>in</strong>surers – ma<strong>in</strong>ly younger<br />

people with no pre-exist<strong>in</strong>g conditions <strong>and</strong> few or no dependants – will leave <strong>the</strong> statutory<br />

health <strong>in</strong>surance scheme. This results <strong>in</strong> self-selection aga<strong>in</strong>st <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme, which closely resembles <strong>the</strong> effects <strong>of</strong> adverse selection <strong>in</strong> <strong>in</strong>surance markets.<br />

Adverse selection arises when <strong>in</strong>surance plans <strong>of</strong>fer<strong>in</strong>g generous benefits are selected by<br />

<strong>in</strong>dividuals with a higher than average risk <strong>of</strong> ill health, caus<strong>in</strong>g <strong>the</strong>se plans to <strong>in</strong>crease<br />

premiums, which <strong>in</strong> turn provokes <strong>in</strong>dividuals with a lower than average risk <strong>of</strong> ill health to<br />

switch to cheaper plans (Cutler <strong>and</strong> Zeckhauser 2000). Ultimately, more generous plans<br />

become f<strong>in</strong>ancially unstable <strong>and</strong> are forced <strong>out</strong> <strong>of</strong> bus<strong>in</strong>ess. Researchers have shown how<br />

adverse selection led to <strong>the</strong> swift collapse <strong>of</strong> <strong>in</strong>demnity <strong>in</strong>surance plans organised by<br />

employers <strong>in</strong> <strong>the</strong> United States (Cutler <strong>and</strong> Zeckhauser 1997).<br />

Where <strong>in</strong>dividuals can choose between statutory <strong>and</strong> VHI coverage, as <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

prior to 1986 <strong>and</strong> <strong>in</strong> <strong>Germany</strong>, <strong>the</strong> statutory health <strong>in</strong>surance scheme is likely to end up<br />

cover<strong>in</strong>g an adverse selection <strong>of</strong> <strong>the</strong> population – predom<strong>in</strong>antly older people, poorer people,<br />

people with pre-exist<strong>in</strong>g conditions or at higher risk <strong>of</strong> ill health <strong>and</strong> people with dependants.<br />

In order to compensate for <strong>the</strong> loss <strong>of</strong> contributions from low risk – <strong>and</strong> possibly wealthier –<br />

people who have opted <strong>out</strong>, <strong>the</strong> statutory health <strong>in</strong>surance scheme may have to <strong>in</strong>crease<br />

contributions from its rema<strong>in</strong><strong>in</strong>g members. Consequently, <strong>the</strong> public burden <strong>of</strong> fund<strong>in</strong>g health<br />

care falls disproportionately on people with low <strong>in</strong>comes <strong>and</strong> <strong>in</strong> poor health, underm<strong>in</strong><strong>in</strong>g risk<br />

5


<strong>and</strong> <strong>in</strong>come solidarity. The situation is compounded when <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme acts as <strong>the</strong> <strong>in</strong>surer <strong>of</strong> last resort, with people who have previously opted <strong>out</strong> return<strong>in</strong>g<br />

to it when <strong>the</strong>y can no longer afford substitutive VHI premiums.<br />

Faced with self-selection aga<strong>in</strong>st <strong>the</strong> statutory health <strong>in</strong>surance scheme, governments can<br />

respond <strong>in</strong> several ways. First, <strong>the</strong>y can prohibit voluntary exit from <strong>the</strong> statutory health<br />

<strong>in</strong>surance scheme (see Table 3 above), ei<strong>the</strong>r by replac<strong>in</strong>g <strong>the</strong> dual system <strong>of</strong> statutory <strong>and</strong><br />

VHI coverage with a s<strong>in</strong>gle system <strong>of</strong> compulsory health <strong>in</strong>surance or by chang<strong>in</strong>g <strong>the</strong> opt <strong>out</strong><br />

policy to an exclusion policy. Second, <strong>the</strong>y can limit <strong>the</strong> voluntary exit <strong>of</strong> some low risk people<br />

by rais<strong>in</strong>g <strong>the</strong> <strong>in</strong>come threshold or reduce <strong>in</strong>centives to opt <strong>out</strong> by prevent<strong>in</strong>g some or all <strong>of</strong><br />

those who opt <strong>out</strong> from return<strong>in</strong>g. Third, <strong>the</strong>y can compel substitutive VHI policy holders to<br />

subsidise those <strong>in</strong>sured by <strong>the</strong> statutory health <strong>in</strong>surance scheme, ei<strong>the</strong>r explicitly or covertly.<br />

Governments <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>and</strong> <strong>in</strong> <strong>Germany</strong> adopted some <strong>of</strong> <strong>the</strong>se measures when<br />

<strong>the</strong>y were confronted with self-selection aga<strong>in</strong>st <strong>the</strong> statutory health <strong>in</strong>surance scheme dur<strong>in</strong>g<br />

<strong>the</strong> 1980s <strong>and</strong> 1990s (Wasem 1995).<br />

The <strong>Health</strong> <strong>Insurance</strong> Act passed <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>in</strong> 1964 (<strong>the</strong> ZFW) established three<br />

separate statutory health <strong>in</strong>surance schemes: a compulsory scheme for employees <strong>and</strong> <strong>the</strong>ir<br />

dependants, a compulsory scheme for older people <strong>and</strong> a voluntary scheme for those not<br />

eligible for cover under <strong>the</strong> compulsory schemes. Eligibility for each <strong>of</strong> <strong>the</strong> schemes was<br />

subject to an <strong>in</strong>come threshold (den Exter et al. 2002). Individuals who were not compulsorily<br />

covered by <strong>the</strong> ZFW could choose between statutory <strong>and</strong> VHI coverage. Initially, most private<br />

health <strong>in</strong>surers rated substitutive VHI premiums on a community basis, so all policy holders<br />

<strong>in</strong>sured by a particular company paid <strong>the</strong> same amount for <strong>the</strong> same level <strong>of</strong> cover. Dur<strong>in</strong>g <strong>the</strong><br />

1970s, however, some <strong>in</strong>surers began to <strong>of</strong>fer discounted premiums for students, to charge<br />

higher premiums for older policy holders, to reject applications <strong>out</strong>right <strong>and</strong> to exclude preexist<strong>in</strong>g<br />

conditions from cover (Gresz et al. 2002b). High risk <strong>in</strong>dividuals were deterred from<br />

leav<strong>in</strong>g <strong>the</strong> statutory health <strong>in</strong>surance scheme by high premiums <strong>and</strong> unfavourable policy<br />

conditions, while low risk <strong>in</strong>dividuals found <strong>the</strong>y were able to obta<strong>in</strong> cheaper coverage from<br />

private <strong>in</strong>surers.<br />

The ensu<strong>in</strong>g exodus <strong>of</strong> younger <strong>and</strong> healthier people from <strong>the</strong> compulsory scheme for older<br />

people <strong>and</strong> <strong>the</strong> voluntary statutory health <strong>in</strong>surance scheme created f<strong>in</strong>ancial difficulties for<br />

<strong>the</strong> ZFW, which faced <strong>in</strong>creas<strong>in</strong>g deficits. In 1986 <strong>the</strong> Dutch government took action to<br />

prevent fur<strong>the</strong>r escalation <strong>of</strong> <strong>the</strong>se deficits. It abolished both schemes, transferr<strong>in</strong>g <strong>the</strong>ir<br />

members to <strong>the</strong> compulsory scheme for employees <strong>and</strong> <strong>the</strong>ir dependants, which was at <strong>the</strong><br />

same time exp<strong>and</strong>ed to cover some people receiv<strong>in</strong>g state benefits (den Exter et al. 2002). In<br />

effect <strong>the</strong> government put an end to <strong>the</strong> opt <strong>out</strong> policy <strong>of</strong> allow<strong>in</strong>g certa<strong>in</strong> <strong>in</strong>dividuals to choose<br />

between statutory <strong>and</strong> VHI coverage, replac<strong>in</strong>g it with <strong>the</strong> exclusion policy that rema<strong>in</strong>s <strong>in</strong><br />

place today.<br />

6


As a result <strong>of</strong> <strong>the</strong> government’s change <strong>of</strong> policy <strong>the</strong> newly-exp<strong>and</strong>ed ZFW found itself<br />

cover<strong>in</strong>g a disproportionately high number <strong>of</strong> elderly people, relative to private <strong>in</strong>surers. The<br />

government <strong>the</strong>refore <strong>in</strong>troduced <strong>the</strong> Act on Jo<strong>in</strong>t Fund<strong>in</strong>g <strong>of</strong> Elderly <strong>Health</strong> <strong>Insurance</strong> Fund<br />

Members (Wet Medef<strong>in</strong>ancier<strong>in</strong>g oververtegenwoordig<strong>in</strong>g Oudere Ziekenfondsverzekerden;<br />

MOOZ), establish<strong>in</strong>g <strong>the</strong> MOOZ, which obliges all substitutive VHI policy holders to make an<br />

annual flat-rate contribution to <strong>the</strong> ZFW. The government also established <strong>the</strong> WTZ (see<br />

above <strong>and</strong> below).<br />

Both <strong>the</strong> MOOZ <strong>and</strong> <strong>the</strong> WTZ are still <strong>in</strong> force today because <strong>the</strong> ZFW cont<strong>in</strong>ues to cover a<br />

disproportionately high number <strong>of</strong> older people (see Table 4). In fact, almost all those aged 65<br />

<strong>and</strong> over who are excluded from <strong>the</strong> ZFW are covered by <strong>the</strong> WTZ, ra<strong>the</strong>r than substitutive<br />

VHI. It is questionable whe<strong>the</strong>r <strong>the</strong> MOOZ has succeeded <strong>in</strong> restor<strong>in</strong>g <strong>the</strong> breach <strong>of</strong> <strong>in</strong>come<br />

<strong>and</strong> risk solidarity caused by <strong>the</strong> opt <strong>out</strong> policy that was <strong>in</strong> place between 1964 <strong>and</strong> 1986.<br />

Annual MOOZ contributions are small, only amount<strong>in</strong>g to ab<strong>out</strong> 5 per cent <strong>of</strong> <strong>the</strong> average<br />

substitutive VHI premium, <strong>and</strong> are unlikely to compensate for <strong>the</strong> low levels <strong>of</strong> <strong>in</strong>come <strong>and</strong><br />

risk solidarity between substitutive VHI <strong>and</strong> <strong>the</strong> ZFW <strong>and</strong> among those who are excluded from<br />

<strong>the</strong> ZFW (Hamilton 1996). Fur<strong>the</strong>rmore, as contributions to <strong>the</strong> ZFW are based on earn<strong>in</strong>gs<br />

ra<strong>the</strong>r than all sources <strong>of</strong> <strong>in</strong>come, substitutive VHI policy holders may <strong>in</strong> fact be subsidis<strong>in</strong>g<br />

some ZFW members who are low earners but have large non-wage <strong>in</strong>comes (Westerh<strong>out</strong><br />

1999).<br />

Insert Table 4 here<br />

The existence <strong>of</strong> an opt <strong>out</strong> policy <strong>in</strong> <strong>Germany</strong> has led to similar issues for <strong>the</strong> statutory health<br />

<strong>in</strong>surance scheme (<strong>the</strong> GKV), although for slightly different reasons. In <strong>the</strong> early 1990s <strong>the</strong><br />

GKV found itself <strong>in</strong> f<strong>in</strong>ancial straits due to <strong>the</strong> fact that it was <strong>in</strong>sur<strong>in</strong>g a disproportionately high<br />

number <strong>of</strong> people with large families, relative to substitutive VHI (Rupprecht et al. 2000).<br />

Because <strong>the</strong> GKV automatically covers its members’ dependants at no extra cost, while<br />

private health <strong>in</strong>surers require policy holders to purchase separate policies for dependants,<br />

family size has always been a critical factor for employees choos<strong>in</strong>g between statutory <strong>and</strong><br />

VHI coverage (Schneider et al. 1992). Clearly, <strong>the</strong> GKV is more attractive to employees with a<br />

higher number <strong>of</strong> dependants. A comparison <strong>of</strong> <strong>the</strong> average annual substitutive VHI premium<br />

(ab<strong>out</strong> DEM 3,500 <strong>in</strong> 1999) <strong>and</strong> <strong>the</strong> average annual maximum GKV contribution (DEM 10,688<br />

overall; DEM 10,805 <strong>in</strong> <strong>the</strong> old Länder <strong>and</strong> DEM 10,570 <strong>in</strong> <strong>the</strong> new Länder) gives some<br />

<strong>in</strong>dication <strong>of</strong> how much a German employee with<strong>out</strong> dependants might save by opt<strong>in</strong>g for<br />

substitutive VHI (Mossialos <strong>and</strong> Thomson 2002). However, an <strong>in</strong>dividual’s actual annual<br />

substitutive VHI premium is likely to be considerably higher than <strong>the</strong> average, as <strong>the</strong> average<br />

also <strong>in</strong>cludes <strong>the</strong> premiums paid by civil servants <strong>and</strong> children, which are substantially lower<br />

than <strong>the</strong> premiums paid by employees <strong>and</strong> self-employed people.<br />

7


At <strong>the</strong> same time <strong>the</strong> GKV came under fur<strong>the</strong>r f<strong>in</strong>ancial pressure caused by an <strong>in</strong>flux <strong>of</strong> older<br />

people who had opted for substitutive VHI when <strong>the</strong>y were younger <strong>and</strong> faced lower<br />

premiums, but could no longer afford to pay <strong>the</strong> premiums dem<strong>and</strong>ed by private health<br />

<strong>in</strong>surers (Wasem 1995). One <strong>of</strong> <strong>the</strong> ways <strong>in</strong> which <strong>the</strong>y were able to do this was by reduc<strong>in</strong>g<br />

<strong>the</strong>ir work<strong>in</strong>g hours prior to retirement, which allowed <strong>the</strong>ir <strong>in</strong>comes to drop below <strong>the</strong><br />

threshold. S<strong>in</strong>ce <strong>the</strong> 1930s substitutive VHI <strong>in</strong> <strong>Germany</strong> has been underwritten <strong>in</strong> <strong>the</strong> same<br />

way as life <strong>in</strong>surance <strong>in</strong> order to protect policy holders. Premiums are loaded to spread costs<br />

over an <strong>in</strong>dividual’s lifetime. Each <strong>in</strong>surer pools premiums for policy holders <strong>in</strong> <strong>the</strong> same age<br />

cohort, <strong>the</strong>reby build<strong>in</strong>g up reserve funds to f<strong>in</strong>ance <strong>the</strong> provision <strong>of</strong> benefits <strong>in</strong> old age.<br />

Insurers are prohibited from term<strong>in</strong>at<strong>in</strong>g contracts, policy holders benefit from lifetime cover<br />

<strong>and</strong> premiums should not, <strong>in</strong> <strong>the</strong>ory, <strong>in</strong>crease as policy holders age. However, an adjustment<br />

clause allows <strong>in</strong>surers to raise premiums if <strong>the</strong>re is any discrepancy between <strong>the</strong> costs used<br />

to calculate premiums <strong>and</strong> <strong>the</strong> actual costs <strong>of</strong> provid<strong>in</strong>g benefits. Dur<strong>in</strong>g <strong>the</strong> 1990s private<br />

health <strong>in</strong>surers used this clause to <strong>in</strong>troduce sharp <strong>in</strong>creases <strong>in</strong> premiums, particularly for<br />

older policy holders. The need to <strong>in</strong>crease premiums stemmed from miscalculation on <strong>the</strong> part<br />

<strong>of</strong> <strong>in</strong>surers ra<strong>the</strong>r than unexpectedly high rates <strong>of</strong> <strong>in</strong>flation ii .<br />

The comb<strong>in</strong>ation <strong>of</strong> a high proportion <strong>of</strong> members with large families <strong>and</strong> <strong>the</strong> return <strong>of</strong> older<br />

people who had not previously contributed to it stretched <strong>the</strong> GKV’s f<strong>in</strong>ances <strong>and</strong> precipitated<br />

a series <strong>of</strong> reforms aimed at restrict<strong>in</strong>g voluntary exit from <strong>the</strong> GKV <strong>and</strong> limit<strong>in</strong>g <strong>the</strong><br />

circumstances under which substitutive VHI policy holders could return to <strong>the</strong> GKV. In 1994<br />

<strong>the</strong> government announced that <strong>the</strong> decision to opt for substitutive VHI would be irreversible<br />

for those aged 65 <strong>and</strong> over (Busse 2000). That is, those who left <strong>the</strong> GKV would not be able<br />

to return to it when <strong>the</strong>y were older, even if <strong>the</strong>ir <strong>in</strong>comes fell below <strong>the</strong> threshold. The Social<br />

<strong>Health</strong> <strong>Insurance</strong> Reform Act <strong>of</strong> 2000 tightened <strong>the</strong> rules fur<strong>the</strong>r by reduc<strong>in</strong>g <strong>the</strong> age<br />

threshold for return<strong>in</strong>g to <strong>the</strong> GKV to 54 (Comité Européen des Assurances 2000). The 2000<br />

Act also addressed <strong>the</strong> problem <strong>of</strong> <strong>in</strong>accurate premium calculations <strong>and</strong> <strong>in</strong>adequate age<strong>in</strong>g<br />

reserves by impos<strong>in</strong>g a surcharge <strong>of</strong> up to 10 per cent <strong>of</strong> <strong>the</strong> gross premium on all new<br />

substitutive VHI policies <strong>and</strong> a premium <strong>in</strong>crease <strong>of</strong> two per cent a year for five years for<br />

exist<strong>in</strong>g policy holders (Datamonitor 2000a). The <strong>in</strong>terest aris<strong>in</strong>g from <strong>the</strong> surcharge is<br />

credited to <strong>the</strong> policy holder <strong>and</strong> used to limit premium <strong>in</strong>creases <strong>in</strong> older age<br />

(Bundesaufsichtsamt für das Versicherungswesen 2001).<br />

Prohibit<strong>in</strong>g substitutive VHI policy holders aged 55 <strong>and</strong> over from return<strong>in</strong>g to <strong>the</strong> GKV is one<br />

way <strong>of</strong> ensur<strong>in</strong>g that GKV contributions do not need to rise to meet <strong>the</strong> cost <strong>of</strong> treat<strong>in</strong>g<br />

<strong>in</strong>dividuals who have not previously contributed to it. But <strong>in</strong> some respects <strong>the</strong> 1994 <strong>and</strong> 2000<br />

reforms may encourage self-selection aga<strong>in</strong>st <strong>the</strong> GKV because those who are risk averse or<br />

who expect to have high levels <strong>of</strong> expenditure on health care <strong>in</strong> <strong>the</strong> future are now less likely<br />

to opt for substitutive VHI. The PKV’s website po<strong>in</strong>ts <strong>out</strong> that substitutive VHI is best value for<br />

8


young <strong>and</strong> healthy people, s<strong>in</strong>gle people <strong>and</strong> double-<strong>in</strong>come couples (PKV 2002b). It also<br />

advises potential policy holders to opt for substitutive VHI as early as possible.<br />

Those purchas<strong>in</strong>g substitutive VHI cont<strong>in</strong>ue to be ma<strong>in</strong>ly young, s<strong>in</strong>gle people or couples with<br />

double <strong>in</strong>comes (Datamonitor 2000a; Datamonitor 2000b). Substitutive VHI policy holders are<br />

also more likely to be adult males liv<strong>in</strong>g <strong>in</strong> <strong>the</strong> old Länder (formerly West <strong>Germany</strong>). In 1999<br />

men accounted for 52.7 per cent <strong>of</strong> those with substitutive VHI, while women only accounted<br />

for 32 per cent <strong>and</strong> children up to <strong>and</strong> <strong>in</strong>clud<strong>in</strong>g 15 years old for 15.3 per cent (PKV 2000).<br />

The low proportion <strong>of</strong> women among those with substitutive VHI may be attributed to <strong>the</strong><br />

lower rate <strong>of</strong> employment for women <strong>and</strong> <strong>the</strong> fact that women have lower earn<strong>in</strong>gs than men<br />

(PKV 2001). Data from 1992 <strong>and</strong> 1993 show that only 4.4 per cent <strong>of</strong> those with substitutive<br />

VHI – <strong>and</strong> 0.8 per cent <strong>of</strong> those with complementary <strong>and</strong> supplementary VHI – were from <strong>the</strong><br />

new Länder (PKV 1994). This discrepancy is still marked; <strong>in</strong> 2001 overall coverage was 11.8<br />

per cent, with 13.5 per cent coverage <strong>in</strong> <strong>the</strong> old Länder compared to only 5.3 per cent<br />

coverage <strong>in</strong> <strong>the</strong> new Länder (Bundesm<strong>in</strong>isterium für Gesundheit 2000; Gesamtverb<strong>and</strong> der<br />

Deutschen Versicherungswirtschaft 2001).<br />

In 2002 <strong>the</strong> government announced its <strong>in</strong>tention to raise <strong>the</strong> <strong>in</strong>come threshold by a higher<br />

than average amount with effect from January 2003 (2002) iii . This has encouraged a larger<br />

than usual exodus from <strong>the</strong> GKV (Fromme <strong>and</strong> Schl<strong>in</strong>gensiepen 2002). While it has not been<br />

possible to obta<strong>in</strong> data ab<strong>out</strong> <strong>the</strong> characteristics <strong>of</strong> those who left <strong>the</strong> GKV between <strong>the</strong> time<br />

<strong>of</strong> <strong>the</strong> announcement <strong>and</strong> January 2003, it is feasible to speculate that most <strong>of</strong> <strong>the</strong>se<br />

<strong>in</strong>dividuals are young <strong>and</strong> <strong>in</strong> good health.<br />

Unlike <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong>re are no explicit attempts to transfer resources from<br />

substitutive VHI policy holders to <strong>the</strong> statutory health <strong>in</strong>surance scheme <strong>in</strong> <strong>Germany</strong>.<br />

However, substitutive VHI policy holders may subsidise <strong>the</strong> GKV <strong>in</strong> a less overt way.<br />

Providers are allowed to charge most privately-<strong>in</strong>sured patients 1.7 or 2.3 times <strong>the</strong><br />

reimbursement values – <strong>and</strong> sometimes even more – set <strong>in</strong> <strong>the</strong> fee schedule for private<br />

medical services issued by <strong>the</strong> M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> (Busse 2000). Substitutive VHI policy<br />

holders may <strong>the</strong>refore subsidise <strong>the</strong> GKV through <strong>the</strong> higher fees <strong>the</strong>y pay to providers, which<br />

prevents <strong>in</strong>flation <strong>of</strong> provider costs <strong>in</strong> <strong>the</strong> GKV. At <strong>the</strong> same time, however, providers have a<br />

f<strong>in</strong>ancial <strong>in</strong>centive to treat privately-<strong>in</strong>sured patients before GKV members, although it is not<br />

clear how much this happens <strong>in</strong> practice.<br />

9


Affordability, choice <strong>and</strong> consumer protection <strong>in</strong> <strong>the</strong> market for<br />

substitutive VHI<br />

One <strong>of</strong> <strong>the</strong> arguments <strong>in</strong> favour <strong>of</strong> allow<strong>in</strong>g people to opt <strong>out</strong> <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme <strong>and</strong> purchase substitutive VHI is that it <strong>in</strong>creases choice for consumers. Even where<br />

people are excluded from statutory coverage, it is expected that <strong>the</strong> market for substitutive<br />

VHI will provide <strong>the</strong>m with a greater degree <strong>of</strong> choice, relative to those who are covered by<br />

<strong>the</strong> statutory health <strong>in</strong>surance scheme. However, a closer analysis <strong>of</strong> <strong>the</strong> way <strong>in</strong> which private<br />

<strong>in</strong>surers operate <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s suggests that while substitutive VHI has <strong>the</strong><br />

potential to <strong>of</strong>fer policy holders a superior level <strong>of</strong> choice, <strong>in</strong> practice choices are constra<strong>in</strong>ed<br />

by <strong>in</strong>sufficient levels <strong>of</strong> <strong>in</strong>formation <strong>and</strong> weak protection for consumers. In <strong>the</strong> German case,<br />

<strong>the</strong> wide range <strong>of</strong> options available to employees with earn<strong>in</strong>gs above <strong>the</strong> <strong>in</strong>come threshold<br />

creates complexities that can be difficult for consumers to unravel (Riemer-Hommel et al.<br />

2003). Choices made at a certa<strong>in</strong> po<strong>in</strong>t <strong>in</strong> time may, at a later stage, turn <strong>out</strong> to have been<br />

sub-optimal.<br />

The behaviour <strong>of</strong> private <strong>in</strong>surers may also prevent certa<strong>in</strong> people from obta<strong>in</strong><strong>in</strong>g an<br />

affordable <strong>and</strong> adequate level <strong>of</strong> cover, particularly those with pre-exist<strong>in</strong>g conditions, women,<br />

families <strong>and</strong> older people. This is an issue that can arise <strong>in</strong> any type <strong>of</strong> VHI market, but it is<br />

more likely to be a matter <strong>of</strong> concern to governments when vulnerable people do not have<br />

recourse to alternative sources <strong>of</strong> coverage, for example from <strong>the</strong> state.<br />

Insurers operat<strong>in</strong>g <strong>in</strong> a market for health <strong>in</strong>surance are less likely to be constra<strong>in</strong>ed <strong>in</strong> <strong>the</strong>ir<br />

behaviour than <strong>the</strong>ir statutory counterparts. In general, <strong>the</strong>y do not have to <strong>of</strong>fer open<br />

enrolment, <strong>the</strong>ir premiums are not required to be <strong>in</strong>dependent <strong>of</strong> ability to pay or risk <strong>of</strong> ill<br />

health <strong>and</strong> <strong>the</strong>y can set <strong>the</strong>ir own policy conditions. This is largely true <strong>of</strong> <strong>the</strong> market for<br />

substitutive VHI <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s (see Table 5), although over time private<br />

<strong>in</strong>surers <strong>in</strong> both countries have become subject to a considerable degree <strong>of</strong> government<br />

<strong>in</strong>tervention due to <strong>the</strong> nature <strong>and</strong> size <strong>of</strong> <strong>the</strong> risk <strong>the</strong>y cover.<br />

Insert Table 5 here<br />

Private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s are free to reject applications, so some high<br />

risk <strong>in</strong>dividuals may not have access to any form <strong>of</strong> substitutive VHI cover. Pre-exist<strong>in</strong>g<br />

conditions can be excluded <strong>out</strong>right or may be covered if disclosed at <strong>the</strong> time <strong>of</strong> underwrit<strong>in</strong>g,<br />

but at extra cost. As previously noted, substitutive VHI does not automatically extend free<br />

coverage to dependants <strong>in</strong> ei<strong>the</strong>r country, which makes family size a critical factor <strong>in</strong><br />

determ<strong>in</strong><strong>in</strong>g affordability, particularly <strong>in</strong> <strong>Germany</strong>. Dutch families with earn<strong>in</strong>gs above <strong>the</strong><br />

<strong>in</strong>come who obta<strong>in</strong> substitutive VHI through <strong>the</strong>ir employers, on a group basis (see below),<br />

10


may be <strong>in</strong> a more favourable position than those who purchase it <strong>in</strong>dividually, because some<br />

group policies only charge premiums for <strong>the</strong> first two children (E<strong>in</strong>dhoven Technical University<br />

2002).<br />

Substitutive VHI premiums are usually based on <strong>the</strong> actuarial pr<strong>in</strong>ciple <strong>of</strong> risk <strong>and</strong> <strong>the</strong> level <strong>of</strong><br />

cover purchased. The price <strong>of</strong> premiums, <strong>and</strong> <strong>the</strong>ir affordability, <strong>the</strong>refore depends on <strong>the</strong><br />

policy holder’s health status <strong>and</strong> <strong>the</strong> type <strong>of</strong> benefits he or she requires. In <strong>Germany</strong><br />

substitutive VHI premiums are adjusted for age, sex <strong>and</strong> health status. This means that<br />

women pay significantly higher premiums than men. The cost <strong>of</strong> a basic substitutive VHI<br />

policy – that is, with<strong>out</strong> supplementary benefits – is 50 per cent higher for women than for<br />

men <strong>in</strong> <strong>the</strong> 20-30 age group, 42 per cent higher <strong>in</strong> <strong>the</strong> 30-40 age group <strong>and</strong> 30 per cent higher<br />

<strong>in</strong> <strong>the</strong> 40-50 age group (PKV 2002a). These differences <strong>in</strong> price are <strong>in</strong>tended to reflect <strong>the</strong><br />

fact that women are likely to live longer than men <strong>and</strong> may <strong>in</strong>cur additional costs associated<br />

with child birth. Most premiums for substitutive VHI <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s are adjusted for age,<br />

so that a 25 year old <strong>and</strong> a 55 year old buy<strong>in</strong>g a policy for <strong>the</strong> first time will be charged<br />

different rates.<br />

Private <strong>in</strong>surers <strong>in</strong> both countries are required to fund benefits <strong>and</strong> rate premiums for<br />

substitutive VHI <strong>in</strong> such a way as to ensure that <strong>the</strong>y do not <strong>in</strong>crease as policy holders age.<br />

However, as <strong>out</strong>l<strong>in</strong>ed above, this has not prevented private health <strong>in</strong>surers from rais<strong>in</strong>g<br />

premiums substantially. Between 1993 <strong>and</strong> 1999 gross written premiums for substitutive <strong>and</strong><br />

o<strong>the</strong>r types <strong>of</strong> VHI <strong>in</strong> <strong>Germany</strong> grew <strong>in</strong> real terms at a compound annual growth rate <strong>of</strong> 5.2<br />

per cent (PKV 1999) iv . Per capita total expenditure on health care grew at <strong>the</strong> much slower<br />

annual rate <strong>of</strong> 4.5 per cent (calculated <strong>in</strong> national currency units at current prices)<br />

(Organisation for Economic Co-operation <strong>and</strong> Development 2000). S<strong>in</strong>ce 1994 <strong>the</strong> real<br />

compound annual growth <strong>in</strong> premiums for substitutive VHI has been lower, at 2.9 per cent,<br />

compared to a growth rate <strong>of</strong> 8.8 per cent for all o<strong>the</strong>r types <strong>of</strong> VHI (Datamonitor 2000b). This<br />

may be due to <strong>the</strong> fact that many private health <strong>in</strong>surers now subsidise <strong>in</strong>creases <strong>in</strong><br />

substitutive VHI premiums from <strong>the</strong>ir own reserves, <strong>in</strong> order to cont<strong>in</strong>ue to attract new<br />

bus<strong>in</strong>ess, ra<strong>the</strong>r than rais<strong>in</strong>g premiums <strong>and</strong> risk<strong>in</strong>g a repeat <strong>of</strong> <strong>the</strong> adverse publicity that<br />

surrounded <strong>the</strong> market <strong>in</strong> <strong>the</strong> early 1990s, when <strong>the</strong>y were criticised for charg<strong>in</strong>g<br />

unreasonable premiums for older policy holders (Datamonitor 2000b). Some private health<br />

<strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> have been able to exploit a loop hole <strong>in</strong> <strong>the</strong> regulatory framework by<br />

barr<strong>in</strong>g new policy holders from enter<strong>in</strong>g exist<strong>in</strong>g risk pools, which means that those already<br />

<strong>in</strong> those risk pools <strong>in</strong>cur higher premiums because <strong>the</strong>y cannot benefit from <strong>the</strong> entry <strong>of</strong> lower<br />

risk policy holders (Riemer-Hommel et al. 2003).<br />

The sale <strong>of</strong> substitutive VHI policies to groups can also affect price <strong>and</strong> affordability. Private<br />

health <strong>in</strong>surers favour group purchas<strong>in</strong>g because it provides high volumes <strong>of</strong> bus<strong>in</strong>ess with<strong>out</strong><br />

a correspond<strong>in</strong>gly large market <strong>out</strong>lay (BMI Europe 2000) <strong>and</strong> because it means that <strong>the</strong>y<br />

11


cover a younger, healthier <strong>and</strong> more homogenous population (Gauthier et al. 1995). In <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s <strong>the</strong> sale <strong>of</strong> policies to groups – usually large companies – has risen substantially<br />

<strong>in</strong> recent years <strong>and</strong> cont<strong>in</strong>ues to be a rapidly grow<strong>in</strong>g sector <strong>of</strong> <strong>the</strong> substitutive VHI market<br />

(Maarse <strong>and</strong> Paulus 1998). Group-purchased policies now account for over half <strong>of</strong> all<br />

substitutive VHI sales (Vektis 2001). Group policy holders ma<strong>in</strong>ly benefit from m<strong>in</strong>imal risk<br />

rat<strong>in</strong>g – age only – <strong>and</strong> cheaper premiums, but <strong>the</strong>y can also receive additional perks, such<br />

as <strong>the</strong> absence <strong>of</strong> wait<strong>in</strong>g periods, a higher proportion <strong>of</strong> benefits <strong>in</strong> k<strong>in</strong>d, free coverage for<br />

any additional child beyond <strong>the</strong> second <strong>and</strong> priority treatment for employees (ter Meulen <strong>and</strong><br />

van der Made 2000; E<strong>in</strong>dhoven Technical University 2002). If <strong>in</strong>surers are part <strong>of</strong> larger<br />

conglomerates sell<strong>in</strong>g o<strong>the</strong>r types <strong>of</strong> <strong>in</strong>surance, as is <strong>of</strong>ten <strong>the</strong> case <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, group<br />

purchas<strong>in</strong>g provides <strong>the</strong>m with <strong>the</strong> opportunity to market <strong>the</strong>ir o<strong>the</strong>r, more pr<strong>of</strong>itable, products<br />

such as life <strong>in</strong>surance (Schut 2002).<br />

Group-purchased substitutive VHI is not common <strong>in</strong> <strong>Germany</strong>. This is partly due to <strong>the</strong> fact<br />

that employers already contribute to <strong>the</strong> cost <strong>of</strong> <strong>in</strong>dividually-purchased substitutive VHI<br />

policies <strong>and</strong> may <strong>the</strong>refore be reluctant to <strong>in</strong>cur fur<strong>the</strong>r expenses <strong>in</strong> sett<strong>in</strong>g up group<br />

schemes, <strong>and</strong> partly due to <strong>the</strong> small numbers <strong>in</strong>volved (Datamonitor 2000b). In 2000 only<br />

five private <strong>in</strong>surers sold substitutive VHI policies to groups, ma<strong>in</strong>ly mult<strong>in</strong>ational corporations<br />

<strong>and</strong> trades unions (Datamonitor 2000b). Currently, group-purchased policies do not differ<br />

substantially <strong>in</strong> price or content from <strong>in</strong>dividually-purchased policies (Schnitzler 2003b).<br />

In <strong>Germany</strong> <strong>the</strong>re are few differences overall <strong>in</strong> <strong>the</strong> level <strong>of</strong> benefits provided by statutory <strong>and</strong><br />

VHI coverage because <strong>the</strong> GKV cont<strong>in</strong>ues to provide a comprehensive range <strong>of</strong> benefits.<br />

Some private <strong>in</strong>surers may <strong>of</strong>fer a slightly wider range <strong>of</strong> benefits than <strong>the</strong> GKV, particularly<br />

for services such as mammography, pharmaceutical prescriptions <strong>and</strong> expensive dental care,<br />

but <strong>in</strong> o<strong>the</strong>r areas GKV benefits may be more generous than those provided by private health<br />

<strong>in</strong>surers – for example, psycho<strong>the</strong>rapy (Mossialos <strong>and</strong> Thomson 2002). However, a major<br />

dist<strong>in</strong>ction between statutory <strong>and</strong> substitutive VHI coverage is that <strong>the</strong> employee opt<strong>in</strong>g for <strong>the</strong><br />

latter has to purchase more than one policy <strong>in</strong> order to obta<strong>in</strong> a comprehensive package <strong>of</strong><br />

benefits. Private health <strong>in</strong>surers <strong>of</strong>fer <strong>out</strong>patient <strong>and</strong> dental benefits separately from <strong>in</strong>patient<br />

benefits, so while policy holders usually enjoy <strong>the</strong> same benefits as those <strong>in</strong>sured by <strong>the</strong><br />

GKV, <strong>the</strong>ir level <strong>of</strong> cover depends on <strong>the</strong> amount <strong>of</strong> policies <strong>the</strong>y buy (Mossialos <strong>and</strong><br />

Thomson 2002). This may not be problematic where <strong>in</strong>patient care is concerned, as <strong>in</strong>patient<br />

benefits are clearly def<strong>in</strong>ed <strong>and</strong> <strong>the</strong>re is not much variation between <strong>in</strong>patient policies, but<br />

policies <strong>of</strong>fer<strong>in</strong>g <strong>out</strong>patient benefits do vary, particularly with regard to marg<strong>in</strong>al benefits such<br />

as psycho<strong>the</strong>rapy, alternative treatment, rehabilitation <strong>and</strong> transport. Some <strong>out</strong>patient policies<br />

may <strong>the</strong>refore <strong>of</strong>fer lower levels <strong>of</strong> coverage than would be provided by <strong>the</strong> GKV. While<br />

employers contribute up to 50 per cent <strong>of</strong> employees’ substitutive VHI premiums – as <strong>in</strong> <strong>the</strong><br />

GKV – but this contribution is limited to <strong>the</strong> average maximum GKV contribution, so that <strong>the</strong><br />

employee bears <strong>the</strong> full cost <strong>of</strong> any additional benefits purchased (Bundesaufsichtsamt für<br />

12


das Versicherungswesen 2001). Consumer associations <strong>in</strong> <strong>Germany</strong> have recently noted that<br />

<strong>in</strong>dividuals f<strong>in</strong>d it <strong>in</strong>creas<strong>in</strong>gly difficult to dist<strong>in</strong>guish between necessary <strong>and</strong> superfluous VHI<br />

products (Datamonitor 2000b).<br />

Substitutive VHI may present lower-<strong>in</strong>come policy holders with f<strong>in</strong>ancial barriers to access<strong>in</strong>g<br />

health care by provid<strong>in</strong>g benefits <strong>in</strong> cash ra<strong>the</strong>r than <strong>in</strong> k<strong>in</strong>d. Unlike GKV <strong>and</strong> ZFW members,<br />

who receive benefits <strong>in</strong> k<strong>in</strong>d, substitutive VHI policy holders generally have to pay providers<br />

directly <strong>and</strong> are subsequently reimbursed by <strong>the</strong>ir <strong>in</strong>surer. In practice, many private <strong>in</strong>surers <strong>in</strong><br />

<strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s provide some benefits <strong>in</strong> k<strong>in</strong>d, particularly to those with group-purchased<br />

policies. Private <strong>in</strong>surers <strong>in</strong> both countries also <strong>of</strong>fer policy holders a range <strong>of</strong> reimbursement<br />

options <strong>and</strong> different levels <strong>of</strong> cost shar<strong>in</strong>g <strong>in</strong> <strong>the</strong> form <strong>of</strong> deductibles. In <strong>Germany</strong>, for<br />

example, an annual deductible <strong>of</strong> €460 for an <strong>out</strong>patient policy lowers <strong>the</strong> premium to ab<strong>out</strong><br />

70 per cent <strong>of</strong> <strong>the</strong> full price (PKV 2001). However, while deductibles reduce <strong>the</strong> price <strong>of</strong><br />

premiums, <strong>the</strong>y also reduce levels <strong>of</strong> coverage (ter Meulen <strong>and</strong> van der Made 2000).<br />

Prior to reforms that took place <strong>in</strong> both countries dur<strong>in</strong>g <strong>the</strong> 1990s, most people covered by<br />

<strong>the</strong> statutory health <strong>in</strong>surance scheme were not able to choose <strong>the</strong>ir sickness fund (Busse<br />

2000; den Exter et al. 2002). Substitutive VHI <strong>the</strong>refore <strong>of</strong>fered its policy holders a clear<br />

advantage by giv<strong>in</strong>g <strong>the</strong>m choice <strong>of</strong> <strong>in</strong>surer. S<strong>in</strong>ce 1993 <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>and</strong> 1996 <strong>in</strong><br />

<strong>Germany</strong>, sickness funds have been subject to price competition on <strong>the</strong> basis <strong>of</strong> <strong>the</strong> variable<br />

flat-rate fee (<strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s) v <strong>and</strong> <strong>the</strong> variable contribution rate (<strong>Germany</strong>). The latter can<br />

vary substantially; <strong>in</strong> some regions employees are able to choose between funds with a<br />

contribution rate <strong>of</strong> 11.2 per cent <strong>and</strong> funds with a contribution rate <strong>of</strong> 15 per cent (Gresz et al.<br />

2002a). Estimates <strong>of</strong> <strong>the</strong> share <strong>of</strong> GKV members switch<strong>in</strong>g sickness fund each year range<br />

from three to five per cent (Gresz et al. 2002a) <strong>and</strong> those who switch tend to be young <strong>and</strong><br />

healthy (Busse 2002). In <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s <strong>the</strong> proportion <strong>of</strong> ZFW members switch<strong>in</strong>g is also<br />

low (Schut 2002).<br />

Substitutive VHI policy holders should be able to obta<strong>in</strong> cheaper coverage by switch<strong>in</strong>g to a<br />

different private <strong>in</strong>surer. However, switch<strong>in</strong>g is a costly option for all but <strong>the</strong> youngest <strong>and</strong><br />

most recently <strong>in</strong>sured substitutive VHI policy holders, partly due to <strong>the</strong> way <strong>in</strong> which premiums<br />

are loaded to reflect age at entry <strong>and</strong> partly due to <strong>the</strong> non-transferability <strong>of</strong> age<strong>in</strong>g reserves<br />

<strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> non-transferability <strong>of</strong> claims histories <strong>in</strong> both countries.<br />

In <strong>Germany</strong> age<strong>in</strong>g reserves cannot be transferred from one <strong>in</strong>surer to ano<strong>the</strong>r, <strong>and</strong><br />

premiums are based on age at entry, so <strong>the</strong>re is a strong <strong>in</strong>centive for substitutive VHI policy<br />

holders to stay where <strong>the</strong>y are ra<strong>the</strong>r than mov<strong>in</strong>g to ano<strong>the</strong>r <strong>in</strong>surer <strong>and</strong> pay<strong>in</strong>g a higher<br />

premium. The government’s recent decision to impose a 10 per cent surcharge on all new<br />

policies (see above) makes it even less attractive for policy holders to move to ano<strong>the</strong>r<br />

<strong>in</strong>surer. Switch<strong>in</strong>g <strong>in</strong>surers may not actually be an option for policy holders who suffer from<br />

13


pre-exist<strong>in</strong>g conditions, as <strong>in</strong>surers are able to reject applications. For this reason <strong>the</strong> PKV<br />

warns people not to leave <strong>the</strong>ir current <strong>in</strong>surer until <strong>the</strong>y have been accepted by ano<strong>the</strong>r (PKV<br />

2002b). Even if switch<strong>in</strong>g is an option, cancellation <strong>and</strong> wait<strong>in</strong>g periods may vary between<br />

<strong>in</strong>surers, so policy holders could f<strong>in</strong>d <strong>the</strong>mselves pay<strong>in</strong>g premiums to <strong>the</strong> old <strong>and</strong> new <strong>in</strong>surer<br />

at <strong>the</strong> same time. With <strong>the</strong> exception <strong>of</strong> a small number <strong>of</strong> young policy holders, movement<br />

between private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> is marg<strong>in</strong>al (Datamonitor 2000b). Private <strong>in</strong>surers have<br />

recently come under pressure to make age<strong>in</strong>g reserves transferable (Riemer-Hommel et al.<br />

2003), but <strong>the</strong>re is concern ab<strong>out</strong> <strong>the</strong> feasibility <strong>of</strong> this proposal <strong>and</strong> some argue that it would<br />

cause a substantial <strong>in</strong>crease <strong>in</strong> <strong>the</strong> price <strong>of</strong> premiums (Schnitzler 2003a).<br />

Switch<strong>in</strong>g from one private <strong>in</strong>surer to ano<strong>the</strong>r also <strong>in</strong>curs additional costs for most substitutive<br />

VHI policy holders <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s. Because claims histories are not transferable, policy<br />

holders become ‘locked <strong>in</strong>’ to <strong>the</strong>ir exist<strong>in</strong>g policy. Switch<strong>in</strong>g is not a realistic option for older<br />

policy holders or those <strong>in</strong> poor health as a new private health <strong>in</strong>surer would charge <strong>the</strong>m<br />

higher premiums. The ris<strong>in</strong>g prevalence <strong>of</strong> group-purchased substitutive VHI <strong>in</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s means that many employees cannot switch <strong>in</strong>surer unless <strong>the</strong>y move to a<br />

different employer. However, as employers are able to negotiate cheaper premiums <strong>and</strong> more<br />

favourable policy conditions, this restriction <strong>of</strong> choice may not always be to <strong>the</strong> employee’s<br />

disadvantage.<br />

Competition for exist<strong>in</strong>g substitutive VHI policy holders is almost non-existent <strong>in</strong> <strong>Germany</strong> <strong>and</strong><br />

rare <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s (Westerh<strong>out</strong> 1999). Although <strong>the</strong>re is strong competition for new<br />

entrants to <strong>the</strong> market <strong>in</strong> both countries – that is, those who cross <strong>the</strong> <strong>in</strong>come threshold for<br />

<strong>the</strong> first time – this does not always benefit <strong>the</strong> consumer. For example, some private <strong>in</strong>surers<br />

<strong>in</strong> <strong>Germany</strong> deliberately miscalculate entry premiums so that <strong>the</strong>y are able to <strong>of</strong>fer lower rates<br />

than <strong>the</strong>ir competitors, <strong>and</strong> <strong>the</strong>n <strong>in</strong>crease premiums once policy holders are locked <strong>in</strong> <strong>and</strong> no<br />

longer able to switch <strong>in</strong>surer with<strong>out</strong> <strong>in</strong>curr<strong>in</strong>g substantial costs (Riemer-Hommel et al. 2003).<br />

The Dutch market also shows signs <strong>of</strong> strong competition for group-purchased policies,<br />

lead<strong>in</strong>g some private <strong>in</strong>surers to price policies below cost <strong>in</strong> order to <strong>in</strong>crease sales, largely <strong>in</strong><br />

<strong>the</strong> hope <strong>of</strong> be<strong>in</strong>g able to market <strong>the</strong>ir o<strong>the</strong>r <strong>in</strong>surance products to substitutive VHI policy<br />

holders (Schut 2002). Because employers are more active <strong>in</strong> purchas<strong>in</strong>g than <strong>in</strong>dividuals,<br />

<strong>the</strong>re is greater movement between private <strong>in</strong>surers <strong>in</strong> this section <strong>of</strong> <strong>the</strong> market.<br />

Substitutive VHI may <strong>of</strong>fer urban policy holders a wider choice <strong>of</strong> providers <strong>in</strong> <strong>Germany</strong>,<br />

where ab<strong>out</strong> three per cent <strong>of</strong> ambulatory doctors are not contracted by <strong>the</strong> GKV, particularly<br />

if <strong>the</strong>se doctors are concentrated <strong>in</strong> <strong>the</strong> major cities (Busse 2000). It is sometimes claimed<br />

that substitutive VHI policy holders receive higher quality care than GKV members <strong>and</strong><br />

preferential access to treatment – because providers can charge higher prices for privately<strong>in</strong>sured<br />

patients – but this claim has not been substantiated, <strong>and</strong> <strong>in</strong> <strong>the</strong> absence <strong>of</strong> wait<strong>in</strong>g<br />

lists, faster access to health care is unlikely to be an issue (Busse 2001).<br />

14


Dutch substitutive VHI policy holders may also benefit from marg<strong>in</strong>ally greater choice <strong>of</strong><br />

provider. Those covered by <strong>the</strong> ZFW are limited to <strong>the</strong> use <strong>of</strong> providers contracted by <strong>the</strong>ir<br />

sickness fund, although most sickness funds have contracts with most providers <strong>in</strong> <strong>the</strong>ir<br />

region, so this rule does not restrict consumer choice <strong>in</strong> practice (den Exter et al. 2002).<br />

However, substitutive VHI policy holders may have faster access to specialists than ZFW<br />

members as private health <strong>in</strong>surers are less strict than sickness funds <strong>in</strong> enforc<strong>in</strong>g <strong>the</strong> gatekeep<strong>in</strong>g<br />

system <strong>in</strong> place (Kulu-Glasgow et al. 1998). Fur<strong>the</strong>rmore, Dutch providers have a<br />

strong <strong>in</strong>centive to treat substitutive VHI policy holders preferentially to ZFW members<br />

because <strong>the</strong>y are paid on a capitation basis for ZFW patients, but on a fee-for-service basis<br />

for privately-<strong>in</strong>sured patients (ter Meulen <strong>and</strong> van der Made 2000).<br />

In both countries substitutive VHI appears to <strong>of</strong>fer some policy holders advantages <strong>in</strong> terms <strong>of</strong><br />

choice <strong>and</strong> price, relative to statutory coverage. Young <strong>and</strong> healthy employees with no or few<br />

dependants are likely to obta<strong>in</strong> cheaper coverage from private health <strong>in</strong>surers than from <strong>the</strong><br />

statutory health <strong>in</strong>surance scheme, particularly <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, where group-purchased<br />

policies are widely available. However, <strong>the</strong>se advantages may be short-lived. As policy<br />

holders age, premiums tend to <strong>in</strong>crease <strong>and</strong> people become locked <strong>in</strong>, unable to switch to<br />

cheaper policies with<strong>out</strong> <strong>in</strong>curr<strong>in</strong>g substantial costs. The difficulty <strong>of</strong> switch<strong>in</strong>g is compounded<br />

by <strong>in</strong>sufficient access to <strong>in</strong>formation ab<strong>out</strong> alternative options.<br />

Given that eligibility for substitutive VHI is determ<strong>in</strong>ed by <strong>the</strong> level <strong>of</strong> an employee’s earn<strong>in</strong>gs,<br />

<strong>and</strong> those purchas<strong>in</strong>g substitutive VHI are <strong>the</strong>refore relatively high earners, it could be argued<br />

that <strong>the</strong>se issues amount to a matter <strong>of</strong> consumer protection ra<strong>the</strong>r than a problem <strong>of</strong> access<br />

to health care. At <strong>the</strong> same time, policy responses to <strong>the</strong> issue <strong>of</strong> self-selection aga<strong>in</strong>st <strong>the</strong><br />

statutory health <strong>in</strong>surance scheme have led to important changes <strong>in</strong> <strong>the</strong> relationship between<br />

statutory <strong>and</strong> substitutive VHI coverage (see above), so that <strong>the</strong> latter is no longer <strong>the</strong><br />

preserve <strong>of</strong> high earn<strong>in</strong>g employees. The comb<strong>in</strong>ation <strong>of</strong> <strong>the</strong>se regulatory changes with<br />

strong <strong>in</strong>centives for private <strong>in</strong>surers to select low risk <strong>in</strong>dividuals <strong>and</strong> restrict access for high<br />

risk <strong>in</strong>dividuals has transformed what may orig<strong>in</strong>ally have been an issue <strong>of</strong> consumer<br />

protection <strong>in</strong>to an issue <strong>of</strong> social protection. For this reason governments <strong>in</strong> both countries<br />

have been obliged to <strong>in</strong>tervene <strong>in</strong> <strong>the</strong> market for substitutive VHI to ensure that more<br />

vulnerable groups are able to obta<strong>in</strong> an affordable <strong>and</strong> adequate level <strong>of</strong> coverage.<br />

Approaches to protect<strong>in</strong>g <strong>the</strong>se groups <strong>of</strong> people range from m<strong>and</strong>atory risk pool<strong>in</strong>g to<br />

guaranteed levels <strong>of</strong> coverage through st<strong>and</strong>ardised benefits, guaranteed prices, enforced<br />

solidarity payments <strong>and</strong> enforced provision <strong>of</strong> <strong>in</strong>formation.<br />

S<strong>in</strong>ce <strong>the</strong> German government restricted substitutive VHI policy holders’ access to <strong>the</strong> GKV <strong>in</strong><br />

1994 <strong>and</strong> 2000 (see above), private <strong>in</strong>surers have been obliged to <strong>of</strong>fer a ‘st<strong>and</strong>ard tariff’<br />

policy to those aged 55 <strong>and</strong> over who have been privately <strong>in</strong>sured for at least 10 years <strong>and</strong><br />

15


whose <strong>in</strong>comes have fallen below <strong>the</strong> threshold. This type <strong>of</strong> policy guarantees access to <strong>the</strong><br />

same level <strong>of</strong> benefits provided by <strong>the</strong> GKV at a price that cannot exceed <strong>the</strong> average<br />

maximum GKV contribution, or 1.5 times <strong>the</strong> contribution for married couples (Comité<br />

Européen des Assurances 1997; PKV 2001). However, <strong>the</strong> st<strong>and</strong>ard tariff policy fails to put<br />

substitutive VHI policy holders with <strong>in</strong>comes below <strong>the</strong> threshold on an even foot<strong>in</strong>g with GKV<br />

members as it does not cover dependants. Even with <strong>the</strong> 50 per cent reduction for spouses,<br />

<strong>the</strong> st<strong>and</strong>ard tariff policy premium is higher than <strong>the</strong> average maximum GKV contribution.<br />

Initially, few substitutive VHI policy holders switched to a st<strong>and</strong>ard tariff policy – only 1,161<br />

people <strong>in</strong> 1998 <strong>and</strong> 1,407 <strong>in</strong> 1999 – perhaps due to lack <strong>of</strong> <strong>in</strong>formation ab<strong>out</strong> whe<strong>the</strong>r or not<br />

<strong>the</strong>y were eligible to switch (PKV 2000). The 2000 Reform Act addressed this issue by<br />

requir<strong>in</strong>g private health <strong>in</strong>surers to <strong>in</strong>form exist<strong>in</strong>g policy holders <strong>of</strong> <strong>the</strong> possibility <strong>of</strong> switch<strong>in</strong>g<br />

to ano<strong>the</strong>r tariff category when <strong>the</strong>ir premiums go up <strong>and</strong> to advise policy holders aged 60 or<br />

over to switch to a st<strong>and</strong>ard tariff policy or to switch to ano<strong>the</strong>r tariff category that provides <strong>the</strong><br />

same benefits for a lower premium (Bundesaufsichtsamt für das Versicherungswesen 2001).<br />

The Act also stipulates that <strong>in</strong>surers must <strong>in</strong>form potential substitutive VHI policy holders <strong>of</strong><br />

<strong>the</strong> likelihood <strong>of</strong> premiums ris<strong>in</strong>g, <strong>the</strong> possibility <strong>of</strong> limit<strong>in</strong>g <strong>the</strong> rise <strong>in</strong> premiums with old age<br />

<strong>and</strong> <strong>the</strong> irreversibility <strong>of</strong> <strong>the</strong> decision to opt <strong>out</strong> <strong>of</strong> <strong>the</strong> GKV (Comité Européen des Assurances<br />

2000; Bundesaufsichtsamt für das Versicherungswesen 2001). Consequently, <strong>in</strong> 2000 <strong>the</strong><br />

number <strong>of</strong> st<strong>and</strong>ard tariff policy holders more than doubled to 3,024. F<strong>in</strong>ally, <strong>the</strong> Act prevents<br />

providers from charg<strong>in</strong>g more than 1.7 times <strong>the</strong> negotiated fee for st<strong>and</strong>ard tariff policy<br />

holders (Bundesaufsichtsamt für das Versicherungswesen 2001).<br />

Although <strong>the</strong> 2000 Reform Act tried to address concerns ab<strong>out</strong> consumer protection, its<br />

provisions only go so far as to oblige private <strong>in</strong>surers to provide <strong>in</strong>formation ab<strong>out</strong> switch<strong>in</strong>g<br />

tariffs to policy holders aged 60 <strong>and</strong> over, so <strong>in</strong>adequate <strong>in</strong>formation is still an issue for<br />

younger substitutive VHI policy holders, as demonstrated by <strong>the</strong> development <strong>of</strong> a market for<br />

<strong>in</strong>dependent <strong>in</strong>surance brokers <strong>and</strong> websites provid<strong>in</strong>g comparative <strong>in</strong>formation on a nonpr<strong>of</strong>it<br />

basis (see, for example, www.stiftung-warentest.de) <strong>and</strong> <strong>the</strong> proliferation <strong>of</strong> price<br />

comparisons published <strong>in</strong> newspapers <strong>and</strong> magaz<strong>in</strong>es. The PKV has also set up a website<br />

rem<strong>in</strong>d<strong>in</strong>g consumers to leave <strong>the</strong> GKV as soon as possible, not to leave one <strong>in</strong>surer until<br />

<strong>the</strong>y have been accepted by ano<strong>the</strong>r <strong>in</strong>surer, that substitutive VHI does not cover ‘certa<strong>in</strong><br />

th<strong>in</strong>gs’ <strong>and</strong> that substitutive VHI premiums are difficult to ‘check up’ (see www.privatekrankenversicherung.net).<br />

The PKV’s website even advises consumers that substitutive VHI<br />

is best value for young <strong>and</strong> healthy s<strong>in</strong>gle people <strong>and</strong> couples with double <strong>in</strong>comes.<br />

After <strong>the</strong> voluntary ZFW scheme <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s was abolished it became clear that<br />

several groups <strong>of</strong> people who were now forced to rely on substitutive VHI – particularly older<br />

people <strong>and</strong> younger self-employed people with pre-exist<strong>in</strong>g conditions – were f<strong>in</strong>d<strong>in</strong>g it<br />

difficult to cover <strong>the</strong> cost <strong>of</strong> premiums. The Dutch government <strong>the</strong>refore <strong>in</strong>troduced <strong>the</strong> <strong>Health</strong><br />

16


<strong>Insurance</strong> Access Act (Wet op de Toegang tot Ziektekostenverzeker<strong>in</strong>gen; WTZ). This Act<br />

guarantees substitutive VHI policy holders aged 65 <strong>and</strong> over access to a ‘st<strong>and</strong>ard’ policy that<br />

provides a similar level <strong>of</strong> benefits to <strong>the</strong> ZFW for a fixed premium vi . Once substitutive policy<br />

holders reach <strong>the</strong> age <strong>of</strong> 65 <strong>the</strong>ir contracts are term<strong>in</strong>ated <strong>and</strong> <strong>the</strong>y switch to a st<strong>and</strong>ard<br />

policy under <strong>the</strong> WTZ. Substitutive VHI policy holders whose premiums have been higher<br />

than <strong>the</strong> WTZ premium for three consecutive years can also switch to <strong>the</strong> WTZ.<br />

The WTZ premium is more than 20 per cent higher than <strong>the</strong> average ZFW contribution, <strong>and</strong><br />

unlike ZFW cover, a st<strong>and</strong>ard policy does not cover <strong>the</strong> policy holder’s dependants, who must<br />

be separately <strong>in</strong>sured. Ano<strong>the</strong>r essential difference from <strong>the</strong> ZFW is that <strong>the</strong> WTZ provides<br />

benefits <strong>in</strong> cash ra<strong>the</strong>r than k<strong>in</strong>d.<br />

After <strong>the</strong> WTZ was established, it was common for private <strong>in</strong>surers to raise <strong>the</strong> premiums <strong>of</strong><br />

high risk substitutive VHI policy holders to such an extent that <strong>the</strong>se policy holders eventually<br />

became eligible for WTZ cover. Because WTZ premiums only cover half <strong>the</strong> cost <strong>of</strong> <strong>the</strong><br />

benefits <strong>the</strong>y provide, private <strong>in</strong>surers receive full compensation from a central equalisation<br />

fund f<strong>in</strong>anced by annual solidarity contributions from substitutive VHI policy holders. This<br />

contribution amounts to ab<strong>out</strong> 16 per cent <strong>of</strong> <strong>the</strong> average substitutive VHI premium for policy<br />

holders aged under 19 <strong>and</strong> ab<strong>out</strong> 32 per cent for policy holders aged 20 to 64. S<strong>in</strong>ce 1986<br />

substitutive VHI has lost 17 per cent <strong>of</strong> its market share to <strong>the</strong> WTZ (Mossialos <strong>and</strong> Thomson<br />

2002). In 1994 <strong>the</strong> Dutch government curbed private <strong>in</strong>surers’ <strong>in</strong>centives to push non-elderly<br />

high risk <strong>in</strong>dividuals <strong>in</strong>to <strong>the</strong> WTZ by restrict<strong>in</strong>g full compensation to WTZ members aged<br />

under 65.<br />

By <strong>the</strong> early 1990s <strong>the</strong> Dutch government realised that <strong>the</strong> WTZ did not fully remove barriers<br />

to access, but did not take action at that time as it was plann<strong>in</strong>g to reform <strong>the</strong> whole system <strong>of</strong><br />

health <strong>in</strong>surance (den Exter et al. 2002). It was only later, when <strong>the</strong>se plans had been<br />

ab<strong>and</strong>oned, that <strong>the</strong> government <strong>in</strong>troduced fur<strong>the</strong>r measures to protect older people – ma<strong>in</strong>ly<br />

by rais<strong>in</strong>g <strong>the</strong> <strong>in</strong>come threshold, so that more older people were eligible for cover under <strong>the</strong><br />

ZFW vii .<br />

Discussion <strong>and</strong> conclusions<br />

Exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s date back to <strong>the</strong> <strong>in</strong>troduction<br />

<strong>of</strong> compulsory health <strong>in</strong>surance for blue-collar workers. Over time <strong>the</strong>y have provided private<br />

<strong>in</strong>surers with strong <strong>in</strong>centives to select low risk <strong>in</strong>dividuals <strong>and</strong> restrict access <strong>and</strong> choice for<br />

high risk <strong>in</strong>dividuals. They have also led to a situation <strong>in</strong> which private <strong>in</strong>surers are able to<br />

shift f<strong>in</strong>ancial risk to o<strong>the</strong>r <strong>in</strong>stitutions. For example, <strong>the</strong> GKV <strong>in</strong> <strong>Germany</strong> acts as <strong>in</strong>surer <strong>of</strong><br />

17


last resort <strong>and</strong> <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s high risk <strong>in</strong>dividuals who are excluded from <strong>the</strong> ZFW can be<br />

covered by <strong>the</strong> WTZ, where <strong>the</strong>ir health care costs are subsidised by non-elderly substitutive<br />

VHI policy holders.<br />

In recent decades governments <strong>in</strong> both countries have <strong>in</strong>tervened heavily <strong>in</strong> <strong>the</strong> market for<br />

substitutive VHI, <strong>in</strong>troduc<strong>in</strong>g reforms to bolster <strong>the</strong> f<strong>in</strong>ances <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme, to ensure access to affordable substitutive cover for vulnerable groups <strong>of</strong> people <strong>and</strong><br />

to <strong>in</strong>crease levels <strong>of</strong> consumer protection. Despite <strong>the</strong>se efforts, <strong>the</strong> complexities created by<br />

<strong>the</strong> existence <strong>of</strong> exclusion <strong>and</strong> opt <strong>out</strong> policies <strong>and</strong> <strong>the</strong> need for successive adjustments<br />

<strong>in</strong>creas<strong>in</strong>gly provoke controversy. Dissatisfaction with <strong>the</strong> current system, comb<strong>in</strong>ed with<br />

concerns ab<strong>out</strong> <strong>the</strong> future susta<strong>in</strong>ability <strong>of</strong> statutory health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> face <strong>of</strong><br />

demographic <strong>and</strong> technological changes, has led to proposals for a radical overhaul <strong>of</strong> health<br />

<strong>in</strong>surance <strong>in</strong> each country.<br />

In 2001 <strong>the</strong> Dutch government announced its <strong>in</strong>tention to ab<strong>and</strong>on <strong>the</strong> policy <strong>of</strong> exclud<strong>in</strong>g<br />

those with <strong>in</strong>comes above <strong>the</strong> threshold from statutory coverage <strong>and</strong> extend ZFW coverage to<br />

<strong>the</strong> whole population (Sheldon 2001; Maarse 2002). However, <strong>the</strong> government was defeated<br />

<strong>in</strong> general elections that took place <strong>the</strong> follow<strong>in</strong>g year. The <strong>in</strong>com<strong>in</strong>g government promised to<br />

<strong>in</strong>troduce a s<strong>in</strong>gle system <strong>of</strong> compulsory health <strong>in</strong>surance for primary <strong>and</strong> acute care<br />

operated by compet<strong>in</strong>g private <strong>in</strong>surers, along <strong>the</strong> l<strong>in</strong>es <strong>of</strong> <strong>the</strong> proposals orig<strong>in</strong>ally mooted by<br />

<strong>the</strong> Dekker Commission <strong>in</strong> <strong>the</strong> late 1980s <strong>and</strong> re-formulated as <strong>the</strong> Simons Plan <strong>in</strong> <strong>the</strong> early<br />

1990s, but this proposal was put on hold by <strong>the</strong> government’s subsequent collapse (Maarse<br />

2002; Hamilton 2003). Key features <strong>of</strong> <strong>the</strong> proposed system <strong>in</strong>cluded open enrolment, flatrate<br />

premiums, tax subsidies to f<strong>in</strong>ance premiums for children, cost shar<strong>in</strong>g <strong>in</strong> <strong>the</strong> form <strong>of</strong> a<br />

m<strong>and</strong>atory m<strong>in</strong>imum deductible <strong>and</strong> risk adjustment between <strong>in</strong>surers.<br />

Reform <strong>of</strong> health <strong>in</strong>surance also played a central role <strong>in</strong> <strong>the</strong> German general election<br />

campaign <strong>in</strong> 2002. Although <strong>the</strong> re-elected government adopted a more moderate approach,<br />

<strong>in</strong>troduc<strong>in</strong>g a reform to restrict people from opt<strong>in</strong>g <strong>out</strong> <strong>of</strong> <strong>the</strong> statutory health <strong>in</strong>surance<br />

scheme (see above), debates ab<strong>out</strong> <strong>the</strong> relationship between statutory <strong>and</strong> substitutive VHI<br />

coverage persist <strong>and</strong>, as <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, <strong>the</strong>re have been calls to abolish <strong>the</strong> dual system<br />

<strong>and</strong> replace it with a compulsory system based on competition between private <strong>in</strong>surers<br />

(Henke 2002).<br />

The Dutch proposals for reform <strong>and</strong> policy debates <strong>in</strong> <strong>Germany</strong> share some similarities,<br />

aris<strong>in</strong>g from mutual dissatisfaction with a dual system that is seen to be overly complex <strong>and</strong><br />

subject to perverse <strong>in</strong>centives. The fact that <strong>the</strong>y both opt for compulsory private health<br />

<strong>in</strong>surance may be <strong>in</strong>dicative <strong>of</strong> a belief <strong>in</strong> <strong>the</strong> ability <strong>of</strong> competitive markets to produce<br />

efficiency ga<strong>in</strong>s, but also reflects strong opposition to a universal statutory system from<br />

<strong>in</strong>terest groups such as private <strong>in</strong>surers, civil servants <strong>and</strong> employers.<br />

18


There are several issues to be considered <strong>in</strong> mov<strong>in</strong>g from a statutory system based on<br />

solidarity pr<strong>in</strong>ciples to a compulsory system operated by private <strong>in</strong>surers. In order to facilitate<br />

competition <strong>and</strong> guarantee real choice for all consumers, compulsory private health <strong>in</strong>surance<br />

would have to be accompanied by a robust system <strong>of</strong> risk adjustment between <strong>in</strong>surers,<br />

improved mobility between plans, <strong>in</strong>creased transparency, st<strong>and</strong>ardised benefits <strong>and</strong> better<br />

<strong>in</strong>formation <strong>and</strong> protection for consumers.<br />

Due to <strong>the</strong>ir capacity to avoid or shift f<strong>in</strong>ancial risk, private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s currently have limited <strong>in</strong>centives to compete on <strong>the</strong> basis <strong>of</strong> price <strong>and</strong> quality.<br />

Although substitutive VHI does appear to <strong>of</strong>fer advantages for some policy holders, <strong>the</strong><br />

possibility <strong>of</strong> real choice <strong>and</strong> lower prices is <strong>of</strong>ten constra<strong>in</strong>ed by <strong>in</strong>sufficient <strong>in</strong>formation <strong>and</strong><br />

weak consumer protection. While some <strong>of</strong> <strong>the</strong>se issues could be addressed – for example, by<br />

<strong>in</strong>troduc<strong>in</strong>g mechanisms to <strong>in</strong>crease mobility between private <strong>in</strong>surers – o<strong>the</strong>rs might be more<br />

difficult to overcome.<br />

Adequate risk adjustment is expensive to adm<strong>in</strong>ister <strong>and</strong> technically difficult to implement<br />

(Beck <strong>and</strong> Zweifel 1998; Puig-Junoy 1999; van de Ven et al. 2000). Even <strong>the</strong> relatively<br />

sophisticated mechanisms currently applied to sickness funds <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s demonstrate limited predictive power <strong>and</strong> do not sufficiently reduce <strong>in</strong>centives to<br />

select risks (Schut <strong>and</strong> van Doorslaer 1999; Busse 2001). An analysis <strong>of</strong> Dutch sickness<br />

funds’ non-medical expenditure, based on a sample <strong>of</strong> sickness funds, shows that <strong>the</strong>y spend<br />

more than three times as much on selection (€10 per member) as on efficiency measures (€3<br />

per member). Risk selection is likely to present a greater challenge under a system <strong>of</strong><br />

compulsory private <strong>in</strong>surance. When <strong>the</strong> non-medical expenditure <strong>of</strong> sickness funds was<br />

compared to that <strong>of</strong> a sample <strong>of</strong> private <strong>in</strong>surers, <strong>the</strong> latter were found to spend almost three<br />

times as much as <strong>the</strong> former on selection (€28 per <strong>in</strong>sured) <strong>and</strong> ab<strong>out</strong> a third less on<br />

efficiency measures (€2) (Douven <strong>and</strong> Westerh<strong>out</strong> 2000).<br />

Given <strong>the</strong> high adm<strong>in</strong>istrative costs <strong>in</strong>curred by private <strong>in</strong>surers, <strong>in</strong>clud<strong>in</strong>g <strong>the</strong> costs <strong>of</strong><br />

selection, it is questionable whe<strong>the</strong>r a system <strong>of</strong> compulsory private health <strong>in</strong>surance would<br />

succeed <strong>in</strong> deliver<strong>in</strong>g <strong>the</strong> efficiency ga<strong>in</strong>s expected from a competitive market. In 1999<br />

German private <strong>in</strong>surers spent 10.2 per cent <strong>of</strong> <strong>the</strong>ir premium <strong>in</strong>come on adm<strong>in</strong>istration,<br />

compared to 5.09 per cent <strong>in</strong> <strong>the</strong> GKV <strong>in</strong> 2000. Private <strong>in</strong>surers <strong>in</strong>volved <strong>in</strong> substitutive VHI<br />

<strong>and</strong> <strong>the</strong> WTZ <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s also spend a much higher proportion <strong>of</strong> <strong>the</strong>ir total costs on<br />

adm<strong>in</strong>istration (12.7 per cent <strong>in</strong> 1999) than sickness funds <strong>in</strong>volved <strong>in</strong> <strong>the</strong> ZFW (4.4 per cent)<br />

(Vektis 2000).<br />

Fur<strong>the</strong>rmore, private <strong>in</strong>surers <strong>in</strong> both countries have been slow to adopt ‘managed care’<br />

strategies such as vertical <strong>in</strong>tegration, selective contract<strong>in</strong>g or monitor<strong>in</strong>g <strong>of</strong> providers’<br />

19


ehaviour to lower <strong>the</strong>ir unit costs. Until recently private <strong>in</strong>surers <strong>in</strong> <strong>Germany</strong> showed a<br />

reluctance to restrict substitutive VHI policy holders’ choice <strong>of</strong> provider through selective<br />

contract<strong>in</strong>g, partly due to <strong>the</strong> provision <strong>of</strong> cash benefits. Some private <strong>in</strong>surers have <strong>in</strong>vested<br />

<strong>in</strong> <strong>the</strong> establishment <strong>of</strong> provider networks (Datamonitor 2000b: 88). In such situations, <strong>the</strong><br />

compensation for restricted choice for policy holders may be <strong>the</strong> receipt <strong>of</strong> benefits <strong>in</strong> k<strong>in</strong>d<br />

ra<strong>the</strong>r than <strong>in</strong> cash. Managed care is not common among Dutch private <strong>in</strong>surers ei<strong>the</strong>r,<br />

largely because <strong>the</strong> substitutive VHI market is fragmented <strong>and</strong> providers tend to be wellorganised,<br />

result<strong>in</strong>g <strong>in</strong> poor barga<strong>in</strong><strong>in</strong>g power for <strong>in</strong>surers (Westerh<strong>out</strong> 1999), but also due to<br />

<strong>the</strong> difficulty <strong>of</strong> obta<strong>in</strong><strong>in</strong>g licences to open cl<strong>in</strong>ics or hospitals <strong>and</strong> o<strong>the</strong>r regulatory restrictions<br />

(Schut 1995; Schut 2002).<br />

Go<strong>in</strong>g beyond technical issues, some analysts have suggested that a system <strong>of</strong> private health<br />

<strong>in</strong>surance with<strong>in</strong> <strong>the</strong> European Union would be subject both to competition law <strong>and</strong> to<br />

legislation on <strong>the</strong> s<strong>in</strong>gle market, particularly as <strong>the</strong> European Commission’s Third non-life<br />

<strong>in</strong>surance directive applies to health <strong>in</strong>surance (European Communities 1992; Raad voor de<br />

Volksgezondheid en Zorg 2000; Palm 2001; Hamilton 2003). This might have negative<br />

consequences for health policy objectives such as accessibility <strong>and</strong> solidarity. Discussion<br />

ab<strong>out</strong> compatibility with EU law has played a key role <strong>in</strong> <strong>the</strong> Dutch context, <strong>in</strong>fluenc<strong>in</strong>g <strong>the</strong><br />

government’s 2001 decision to extend <strong>the</strong> ZFW.<br />

Analysis <strong>of</strong> <strong>the</strong> way <strong>in</strong> which private <strong>in</strong>surers <strong>of</strong>fer<strong>in</strong>g substitutive VHI operate <strong>in</strong> <strong>Germany</strong> <strong>and</strong><br />

<strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s raises serious questions ab<strong>out</strong> <strong>the</strong> equity <strong>and</strong> efficiency implications <strong>of</strong><br />

mov<strong>in</strong>g to a system <strong>of</strong> compulsory private health <strong>in</strong>surance. Although <strong>the</strong> dual existence <strong>of</strong><br />

statutory <strong>and</strong> substitutive VHI results <strong>in</strong> <strong>in</strong>efficiencies <strong>and</strong> may <strong>in</strong>flate costs <strong>in</strong> <strong>the</strong> health<br />

system as a whole, replac<strong>in</strong>g <strong>the</strong> current system with compulsory private health <strong>in</strong>surance is<br />

unlikely fully to address exist<strong>in</strong>g concerns <strong>and</strong> may give rise to fur<strong>the</strong>r challenges.<br />

20


Tables<br />

Table 1 <strong>Statutory</strong> health <strong>in</strong>surance <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, 2002<br />

<strong>Germany</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

<strong>Statutory</strong> coverage (% population) GKV compulsory 75%<br />

GKV voluntary 13%<br />

LTC 100%<br />

Employee contributions (% <strong>of</strong> gross<br />

earn<strong>in</strong>gs)<br />

Employer contributions (% <strong>of</strong><br />

employee’s gross earn<strong>in</strong>gs)<br />

variable; average 6.75% <strong>of</strong><br />

gross earn<strong>in</strong>gs<br />

variable; average 6.75% <strong>of</strong><br />

employee’s gross earn<strong>in</strong>gs<br />

Annual <strong>in</strong>come threshold €45,900 (raised from €41,400<br />

<strong>in</strong> 2003)<br />

AWBZ 100%<br />

ZFW 65%<br />

1.70% (ZFW)<br />

10.25% (AWBZ)<br />

6.25% (ZFW)<br />

0% (AWBZ)<br />

€30,700 (ZFW)<br />

Source: Authors’ estimates based on MISSOC 2003, Busse 2000 <strong>and</strong> den Exter 2002<br />

21


Table 2 Different levels <strong>of</strong> health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, 2000<br />

Type <strong>of</strong> care Scheme Insurers %<br />

covered<br />

Type %<br />

TEH<br />

First level 44%<br />

Long-term care<br />

Mental health care<br />

Care for disabled<br />

people<br />

AWBZ<br />

Sickness funds<br />

<strong>and</strong> private<br />

<strong>in</strong>surers<br />

100.0 Compulsory<br />

Second level 53%<br />

Outpatient <strong>and</strong> ZFW Sickness funds 64.6 Compulsory<br />

<strong>in</strong>patient care<br />

Substitutive VHI Private <strong>in</strong>surers 24.7 Voluntary<br />

WTZ* Private <strong>in</strong>surers 4.2 Voluntary<br />

PZV** Sickness funds 4.9 Compulsory<br />

Un<strong>in</strong>sured - 1.6 -<br />

Third level 3%<br />

O<strong>the</strong>r Complementary /<br />

Supplementary<br />

VHI<br />

Sickness funds<br />

<strong>and</strong> private<br />

<strong>in</strong>surers<br />

Source: Authors’ estimates based on Vektis 2000 <strong>and</strong> den Exter 2002<br />

TEH: total expenditure on health care<br />

* WTZ: scheme created by <strong>the</strong> 1986 <strong>Health</strong> <strong>Insurance</strong> Access Act<br />

** PZV: scheme for civil servants<br />

60.0 Voluntary<br />

22


Table 3 <strong>Health</strong> <strong>in</strong>surance options <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, 2002<br />

<strong>Germany</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

People with earn<strong>in</strong>gs / <strong>in</strong>comes under <strong>the</strong> threshold<br />

Employees <strong>and</strong> <strong>the</strong>ir<br />

Compulsory GKV members Compulsory ZFW members<br />

dependants<br />

Self-employed<br />

Excluded from <strong>the</strong> GKV unless Compulsory ZFW members<br />

<strong>the</strong>y have been members<br />

previously<br />

Aged 65+ Compulsory GKV members Voluntary ZFW members<br />

Voluntary exit from <strong>the</strong> ZFW<br />

People with earn<strong>in</strong>gs / <strong>in</strong>comes above <strong>the</strong> threshold<br />

Employees <strong>and</strong> <strong>the</strong>ir<br />

Voluntary GKV members Excluded from <strong>the</strong> ZFW<br />

dependants<br />

Voluntary exit from <strong>the</strong> GKV<br />

Self-employed<br />

Excluded from <strong>the</strong> GKV unless Excluded from <strong>the</strong> ZFW<br />

<strong>the</strong>y have been members<br />

previously<br />

Aged 65+<br />

Voluntary GKV members<br />

Voluntary exit from <strong>the</strong> GKV<br />

Voluntary ZFW members<br />

Voluntary exit from <strong>the</strong> ZFW<br />

O<strong>the</strong>r groups<br />

Civil servants Excluded from <strong>the</strong> GKV Compulsory PZV members<br />

Substitutive VHI policy holders<br />

aged < 65<br />

Substitutive VHI policy holders<br />

aged 65+<br />

Entry to <strong>the</strong> GKV only if <strong>the</strong>y are<br />

< 55 <strong>and</strong> <strong>the</strong>ir <strong>in</strong>comes fall<br />

below <strong>the</strong> threshold<br />

No entry to <strong>the</strong> GKV for those<br />

aged 55+<br />

Entry to <strong>the</strong> WTZ only if <strong>the</strong>ir<br />

premiums are higher than <strong>the</strong><br />

maximum for <strong>the</strong>ir age group<br />

<strong>and</strong> <strong>the</strong>y have been privately<br />

<strong>in</strong>sured for at least 3 years<br />

Compulsory exit from<br />

substitutive VHI<br />

Voluntary entry to <strong>the</strong> WTZ<br />

Source: Authors’ estimates based on Busse 2000 <strong>and</strong> den Exter 2002<br />

Note: Where people can voluntarily exit <strong>the</strong> GKV or ZFW, <strong>the</strong>y can purchase substitutive VHI<br />

or be un<strong>in</strong>sured.<br />

23


Table 4 Age distribution <strong>in</strong> <strong>the</strong> Dutch population, <strong>the</strong> ZFW, substitutive VHI <strong>and</strong> <strong>the</strong><br />

WTZ <strong>in</strong> 2000<br />

Age % Population % ZFW % Substitutive<br />

VHI <strong>and</strong> WTZ<br />

0-19 24.4 21.3 30.9<br />

20-64 62.0 63.4 59.0<br />

65+ 13.6 15.2 10.1<br />

Total 100.0 100.0 100.0<br />

Source: Vektis 2000<br />

24


Table 5 Aspects <strong>of</strong> substitutive VHI market conduct <strong>in</strong> <strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s<br />

<strong>Germany</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s<br />

Open enrolment No No<br />

Can <strong>in</strong>surers reject Yes<br />

Yes<br />

applications?<br />

Pre-exist<strong>in</strong>g conditions Excluded if known at time <strong>of</strong><br />

underwrit<strong>in</strong>g <strong>and</strong> not disclosed;<br />

covered for a higher premium if<br />

declared<br />

Can be excluded or covered for a<br />

higher premium<br />

Premium rat<strong>in</strong>g Risk rat<strong>in</strong>g (age, sex, health status) Risk rat<strong>in</strong>g (age)<br />

Dependants covered? Must purchase separate policy Must purchase separate policy<br />

Employer contribution Up to 50% up to GKV average<br />

maximum contribution; only to<br />

specialist <strong>in</strong>surers<br />

No<br />

Can <strong>in</strong>surers term<strong>in</strong>ate<br />

policy?<br />

No<br />

No; but policies automatically<br />

term<strong>in</strong>ated at age 65 with move to<br />

<strong>the</strong> WTZ<br />

Cover Lifetime Annual<br />

Fund<strong>in</strong>g system Capital: non-transferable age<strong>in</strong>g Pay as you go: pool<strong>in</strong>g by age group<br />

reserves<br />

Sales to groups (%<br />

total sales)<br />

Choice <strong>of</strong> <strong>in</strong>surer<br />

6.5% 34.5% <strong>in</strong> 1980; 53.8% <strong>in</strong> 1998 <strong>and</strong><br />

55.9% <strong>in</strong> 2001<br />

Yes; but <strong>in</strong> practice limited to new<br />

entrants<br />

Choice <strong>of</strong> benefits Yes Yes<br />

St<strong>and</strong>ard package<br />

required by law<br />

Benefits <strong>in</strong> cash or <strong>in</strong><br />

k<strong>in</strong>d?<br />

No; benefits similar to GKV, but wide<br />

variations at <strong>the</strong> marg<strong>in</strong><br />

Insured are ma<strong>in</strong>ly reimbursed;<br />

some benefits <strong>in</strong> k<strong>in</strong>d<br />

Yes; but <strong>in</strong> practice limited to new<br />

entrants<br />

No; benefits similar to ZFW, but<br />

variations at <strong>the</strong> marg<strong>in</strong><br />

Insured are ma<strong>in</strong>ly reimbursed;<br />

some benefits <strong>in</strong> k<strong>in</strong>d<br />

Cost shar<strong>in</strong>g Yes; usually deductibles Yes; usually deductibles<br />

Sources: Authors’ estimates based on various sources<br />

25


References<br />

Alber, J. (1986). <strong>Germany</strong>. In Growth to limits: <strong>the</strong> western European welfare states s<strong>in</strong>ce<br />

World War II. P. Flora, Ed. Berl<strong>in</strong>, Walter de Gruyter.<br />

Anonymous (2002). [Erst ab 5.100 Euro zu den Privaten], 17 October 2002. Süddeutsche<br />

Zeitung. Munich.<br />

Barr, N. (1992). 'Economic <strong>the</strong>ory <strong>and</strong> <strong>the</strong> welfare state: a survey <strong>and</strong> <strong>in</strong>terpretation.' Journal<br />

<strong>of</strong> Economic Literature 30: 741-803.<br />

Beck, K. <strong>and</strong> P. Zweifel (1998). 'Cream-skimm<strong>in</strong>g <strong>in</strong> deregulated social health <strong>in</strong>surance:<br />

evidence from Switzerl<strong>and</strong>.' Dev <strong>Health</strong> Econ Public Policy 6: 211-27.<br />

Blackwell, N. <strong>and</strong> D. Kruger (2002). Better healthcare for all: replac<strong>in</strong>g <strong>the</strong> NHS monopoly,<br />

The <strong>in</strong>itial report <strong>of</strong> <strong>the</strong> CPS <strong>Health</strong> Policy Group. London, Centre for Policy Studies.<br />

Blanpa<strong>in</strong>, J., L. Delesie <strong>and</strong> H. Nys (1978). National health <strong>in</strong>surance <strong>and</strong> health resources:<br />

<strong>the</strong> European experience. Cambridge, Massachusetts, Harvard University Press.<br />

BMI Europe (2000). Medical <strong>in</strong>surance, http://www.bmieurope.com/cover/medical.html. 2000.<br />

Bundesaufsichtsamt für das Versicherungswesen (2001). Unpublished submission to <strong>the</strong><br />

report on voluntary health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> European Union prepared for <strong>the</strong><br />

Directorate General for Employment <strong>and</strong> Social Affairs <strong>of</strong> <strong>the</strong> European Commission.<br />

Berl<strong>in</strong>, Bundesaufsichtsamt für das Versicherungswesen.<br />

Bundesm<strong>in</strong>isterium für Gesundheit (2000). Statistisches Taschenbuch Gesundheit 2000.<br />

Bonn, Bundesm<strong>in</strong>isterium für Gesundheit.<br />

Busse, R. (2000). <strong>Health</strong> care systems <strong>in</strong> transition: <strong>Germany</strong>. Copenhagen, European<br />

Observatory on <strong>Health</strong> Care Systems.<br />

Busse, R. (2001). 'Risk structure compensation <strong>in</strong> <strong>Germany</strong>'s statutory health <strong>in</strong>surance.'<br />

European Journal <strong>of</strong> Public <strong>Health</strong> 11(2): 174-177.<br />

Busse, R. (2002). <strong>Germany</strong>. In <strong>Health</strong> care systems <strong>in</strong> eight countries: trends <strong>and</strong> challenges.<br />

Report commissioned by <strong>the</strong> <strong>Health</strong> Trends Review, HM Treasury. A. Dixon <strong>and</strong> E.<br />

Mossialos, Eds. London, European Observatory on <strong>Health</strong> Care Systems.<br />

Comité Européen des Assurances (1997). <strong>Health</strong> <strong>Insurance</strong> <strong>in</strong> Europe 1997. Paris, CEA.<br />

Comité Européen des Assurances (2000). <strong>Health</strong> <strong>in</strong>surance <strong>in</strong> Europe: 1998 data, CEA ECO<br />

12 (July 2000). Paris, CEA.<br />

Cox, R. H. (1993). The development <strong>of</strong> <strong>the</strong> Dutch welfare state: from workers' <strong>in</strong>surance to<br />

universal entitlement. Pittsburgh, University <strong>of</strong> Pittsburgh Press.<br />

Cutler, D. <strong>and</strong> R. J. Zeckhauser (2000). The anatomy <strong>of</strong> health <strong>in</strong>surance. In H<strong>and</strong>book <strong>of</strong><br />

health economics, Volume 1A. A. Culyer <strong>and</strong> J. P. Newhouse, Eds. Amsterdam,<br />

Elsevier Science.<br />

Cutler, D. M. <strong>and</strong> R. J. Zeckhauser (1997). Adverse selection <strong>in</strong> health <strong>in</strong>surance, NBER<br />

Work<strong>in</strong>g Paper 6107. Cambridge, National Bureau <strong>of</strong> Economic Research.<br />

26


Datamonitor (2000a). European health <strong>in</strong>surance 2000: what's <strong>the</strong> prognosis, doctor?<br />

London, Datamonitor.<br />

Datamonitor (2000b). Long term care <strong>and</strong> health <strong>in</strong>surance <strong>in</strong> <strong>Germany</strong> 2000: car<strong>in</strong>g for <strong>the</strong><br />

future? London, Datamonitor.<br />

den Exter, A., H. E. Hermans <strong>and</strong> M. Dosljak (2002). <strong>Health</strong> care systems <strong>in</strong> transition:<br />

Ne<strong>the</strong>rl<strong>and</strong>s. Copenhagen, European Observatory on <strong>Health</strong> Care Systems.<br />

Douven, R. <strong>and</strong> E. Westerh<strong>out</strong> (2000). 'Reimbursement systems <strong>in</strong> Dutch sickness funds.'<br />

CPB Report 2000(3): 51-55.<br />

E<strong>in</strong>dhoven Technical University (2002). The group health <strong>in</strong>surance <strong>of</strong> VGZ,<br />

http://www.tue.nl/dpo/sjablonen/9902883%20VGZ-Brochure%20Engels.pdf, access<br />

date 30 July 2002. E<strong>in</strong>dhoven, E<strong>in</strong>dhoven Technical University.<br />

European Communities (1992). 'Council Directive 92/49/EEC <strong>of</strong> 18 June 1992 on <strong>the</strong><br />

coord<strong>in</strong>ation <strong>of</strong> laws, regulations <strong>and</strong> adm<strong>in</strong>istrative provisions relat<strong>in</strong>g to direct<br />

<strong>in</strong>surance o<strong>the</strong>r than life assurance <strong>and</strong> amend<strong>in</strong>g Directives 73/239/EEC <strong>and</strong><br />

88/357/EEC (Third non-life <strong>in</strong>surance directive).' OJEC L 228(11 August 1992): 1-23.<br />

Fromme, H. <strong>and</strong> I. Schl<strong>in</strong>gensiepen (2002). [Privater Krankenschutz wird teurer], 7 August<br />

2002. F<strong>in</strong>ancial Times Deutschl<strong>and</strong>. Hamburg.<br />

Gauthier, A., J. Lamphere <strong>and</strong> N. Barr<strong>and</strong> (1995). 'Risk selection <strong>in</strong> <strong>the</strong> health care market: a<br />

workshop overview.' Inquiry 32: 14-22.<br />

Gesamtverb<strong>and</strong> der Deutschen Versicherungswirtschaft (2001). The German <strong>in</strong>surance<br />

<strong>in</strong>dustry: 2001 yearbook. Berl<strong>in</strong>, Gesamtverb<strong>and</strong> der Deutschen<br />

Versicherungswirtschaft e. V.<br />

Gresz, S., P. Groenewegen, J. Kerssens, B. Braun <strong>and</strong> J. Wasem (2002a). 'Free choice <strong>of</strong><br />

sickness fund <strong>in</strong> regulated competition: evidence from <strong>Germany</strong> <strong>and</strong> <strong>the</strong><br />

Ne<strong>the</strong>rl<strong>and</strong>s.' <strong>Health</strong> Policy 60: 235-254.<br />

Gresz, S., K. Okma <strong>and</strong> J. Wasem (2002b). Private health <strong>in</strong>surance <strong>in</strong> social health<br />

<strong>in</strong>surance countries: market <strong>out</strong>comes <strong>and</strong> policy implications, Discussion Paper<br />

01/2002. Greifswald, Ernst-Moritz-Arndt Universität Greifswald.<br />

Hamilton, G. J. (1996). 'Changes <strong>in</strong> <strong>the</strong> health <strong>in</strong>surance system <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s.'<br />

European Journal <strong>of</strong> <strong>Health</strong> Law 3: 359-371.<br />

Hamilton, G. J. (2003). 'Private <strong>in</strong>surance for all <strong>in</strong> <strong>the</strong> Dutch health care system?' European<br />

Journal <strong>of</strong> <strong>Health</strong> Law 10(1): 53-61.<br />

Henke, K.-D. (2002). 'The permanent crisis <strong>in</strong> German healthcare.' Eurohealth 8(2): 26-28.<br />

Howard, M. (2003). Reform <strong>of</strong> <strong>the</strong> public services: <strong>the</strong> boundary between <strong>the</strong> private <strong>and</strong><br />

public sectors, Lecture given to <strong>the</strong> Centre for Policy Studies on 24 March 2003.<br />

London, Centre for Policy Studies.<br />

Katzenste<strong>in</strong>, P. J. (1987). Policy <strong>and</strong> politics <strong>in</strong> West <strong>Germany</strong>: <strong>the</strong> growth <strong>of</strong> a semisovereign<br />

state. Philadelphia, Temple University Press.<br />

Kulu-Glasgow, I., D. Delnoij <strong>and</strong> D. de Bakker (1998). 'Self-referral <strong>in</strong> a gatekeep<strong>in</strong>g system:<br />

patients' reasons for skipp<strong>in</strong>g <strong>the</strong> general practitioner.' <strong>Health</strong> Policy 45: 221-23.<br />

27


Maarse, H. (2002). '<strong>Health</strong> <strong>in</strong>surance reform (aga<strong>in</strong>) <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s: will it succeed?' Euro<br />

Observer 4(3): 1-3.<br />

Maarse, H. <strong>and</strong> A. Paulus (1998). <strong>Health</strong> <strong>in</strong>surance reforms <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, Belgium <strong>and</strong><br />

<strong>Germany</strong>: a comparative analysis. In <strong>Health</strong> care <strong>and</strong> its f<strong>in</strong>anc<strong>in</strong>g <strong>in</strong> <strong>the</strong> s<strong>in</strong>gle<br />

European market. R. Leidl, Ed. Oxford, IOS Press: 230-53.<br />

M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport (2000). Personal communication with <strong>the</strong> M<strong>in</strong>istry's<br />

Public Information Office.<br />

M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong> Welfare <strong>and</strong> Sport (2002). <strong>Health</strong> <strong>in</strong>surance <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s: status as <strong>of</strong><br />

1 January 2002. The Hague, M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong>, Welfare <strong>and</strong> Sport.<br />

Mossialos, E. <strong>and</strong> S. Thomson (2002). Voluntary health <strong>in</strong>surance <strong>in</strong> <strong>the</strong> European Union:<br />

report prepared for <strong>the</strong> Directorate General for Employment <strong>and</strong> Social Affairs <strong>of</strong> <strong>the</strong><br />

European Commission, available onl<strong>in</strong>e at:<br />

http://europa.eu.<strong>in</strong>t/comm/employment_social/soc-prot/social/<strong>in</strong>dex_en.htm. London,<br />

London School <strong>of</strong> Economics <strong>and</strong> Political Science.<br />

Organisation for Economic Co-operation <strong>and</strong> Development (2000). <strong>Health</strong> Data 2000. Paris,<br />

Organisation for Economic Co-operation <strong>and</strong> Development.<br />

Organisation for Economic Co-operation <strong>and</strong> Development (2001). <strong>Health</strong> Data 2001. Paris,<br />

Organisation for Economic Co-operation <strong>and</strong> Development.<br />

Organisation for Economic Co-operation <strong>and</strong> Development (2002). <strong>Health</strong> Data 2002. Paris,<br />

Organisation for Economic Co-operation <strong>and</strong> Development.<br />

Palm, W. (2001). Voluntary health <strong>in</strong>surance <strong>and</strong> EU <strong>in</strong>surance directives: between solidarity<br />

<strong>and</strong> <strong>the</strong> market. Brussels, Association Internationale de la Mutualité.<br />

PKV (1994). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 1992/93. Köln, Verb<strong>and</strong> der privaten<br />

Krankenversicherung e.V.<br />

PKV (1999). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 1998/1999, available onl<strong>in</strong>e at:<br />

http://www.pkv.de/default.asp. Köln, Verb<strong>and</strong> der privaten Krankenversicherung e.V.<br />

PKV (2000). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 1999/2000, available onl<strong>in</strong>e at:<br />

http://www.pkv.de/default.asp. Köln, Verb<strong>and</strong> der privaten Krankenversicherung e.V.<br />

PKV (2001). Private health <strong>in</strong>surance: facts <strong>and</strong> figures 2000/2001, available onl<strong>in</strong>e at:<br />

http://www.pkv.de/default.asp. Köln, Verb<strong>and</strong> der privaten Krankenversicherung e.V.<br />

PKV (2002a). e-PKV, www.e-pkv.de. 2002.<br />

PKV (2002b). Private-Krankenversicherung.net, http://www.privatekrankenversicherung.net/<strong>in</strong>dex.htm.<br />

2002.<br />

Puig-Junoy, J. (1999). 'Manag<strong>in</strong>g risk selection <strong>in</strong>centives <strong>in</strong> health sector reforms.'<br />

International Journal <strong>of</strong> <strong>Health</strong> Plann<strong>in</strong>g <strong>and</strong> Management 14: 287-311.<br />

Raad voor de Volksgezondheid en Zorg (2000). Europe <strong>and</strong> healthcare, 11 January 2000,<br />

http://www.rvz.net/Samenvat/Werk99/europe.htm. 2000.<br />

Riemer-Hommel, P., U. Hommel, A. Kemper <strong>and</strong> H. Farag (2003). Regulat<strong>in</strong>g <strong>the</strong> choice<br />

between public <strong>and</strong> private coverage: an option-based analysis <strong>of</strong> <strong>the</strong> German health<br />

<strong>in</strong>surance system, Work<strong>in</strong>g Paper. Trier, University <strong>of</strong> Trier.<br />

28


Rosenberg, P. (1986). The orig<strong>in</strong> <strong>and</strong> <strong>the</strong> development <strong>of</strong> compulsory health <strong>in</strong>surance <strong>in</strong><br />

<strong>Germany</strong>. In Political values <strong>and</strong> health care: <strong>the</strong> German experience. D. Light <strong>and</strong> A.<br />

Schuller, Eds. Cambridge, Massachusetts, The MIT Press.<br />

Rupprecht, F., B. Tissot <strong>and</strong> F. Chatel (2000). 'German health care system: promot<strong>in</strong>g greater<br />

responsibility among all system players.' INSEE Studies 42(January 2000).<br />

Schneider, M., R. K. Dennerle<strong>in</strong>, A. Kose <strong>and</strong> L. Scholtes (1992). '<strong>Health</strong> care <strong>in</strong> <strong>the</strong> EC<br />

member states.' <strong>Health</strong> Policy 20(1-2): 1-251.<br />

Schnitzler, F. (2003a). Personal communication, 3 March 2003.<br />

Schnitzler, F. (2003b). Personal correspondence, 3 April 2003.<br />

Schut, F. (2002). Personal communication.<br />

Schut, F. <strong>and</strong> E. van Doorslaer (1999). 'Towards a re<strong>in</strong>forced agency role <strong>of</strong> health <strong>in</strong>surers <strong>in</strong><br />

Belgium <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s.' <strong>Health</strong> Policy 48: 47-67.<br />

Schut, F. T. (1995). '<strong>Health</strong> care reform <strong>in</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s: balanc<strong>in</strong>g corporatism, etatism,<br />

<strong>and</strong> market mechanisms.' J <strong>Health</strong> Polit Policy Law 20(3): 615-52.<br />

Sheldon, A. (2001). 'Dutch government plans to reform health <strong>in</strong>surance system.' British<br />

Medical Journal 323: 70.<br />

ter Meulen, R. <strong>and</strong> J. van der Made (2000). 'The extent <strong>and</strong> limits <strong>of</strong> solidarity <strong>in</strong> Dutch health<br />

care.' International Journal <strong>of</strong> Social Welfare 9: 250-260.<br />

van de Ven, W. P. M. M., R. C. J. A. van Vliet, F. T. Schut <strong>and</strong> E. M. van Barneveld (2000).<br />

'Access to coverage for high-risks <strong>in</strong> a competitive <strong>in</strong>dividual health <strong>in</strong>surance market:<br />

via premium rate restrictions or risk-adjusted premium subsidies?' Journal <strong>of</strong> <strong>Health</strong><br />

Economics 19: 311-339.<br />

Vektis (2000). Zorgmonitor. Zeist, Vektis.<br />

Vektis (2001). Zorg<strong>the</strong>rmometer 2001. Zeist, Vektis.<br />

Wasem, J. (1995). Regulat<strong>in</strong>g private health <strong>in</strong>surance markets. In Four country conference<br />

on health care reforms <strong>and</strong> health care policies <strong>in</strong> <strong>the</strong> United States, Canada,<br />

<strong>Germany</strong> <strong>and</strong> <strong>the</strong> Ne<strong>the</strong>rl<strong>and</strong>s, Amsterdam, February 23-25 1995. K. Okma, Ed.<br />

Amsterdam, M<strong>in</strong>istry <strong>of</strong> <strong>Health</strong>, Welfare <strong>and</strong> Sport.<br />

Westerh<strong>out</strong>, E. (1999). 'The future <strong>of</strong> <strong>the</strong> Dutch health <strong>in</strong>surance system.' CPB Report<br />

1999(4): 21-26.<br />

i<br />

Substitutive VHI can be dist<strong>in</strong>guished from o<strong>the</strong>r types <strong>of</strong> VHI available with<strong>in</strong> <strong>the</strong> European Union. Complementary<br />

VHI is purchased to cover services only partially covered or excluded by <strong>the</strong> statutory health <strong>in</strong>surance scheme (for<br />

example, statutory user charges or dental care). Supplementary VHI is purchased to cover faster access <strong>and</strong><br />

<strong>in</strong>creased choice <strong>of</strong> treatment or provider.<br />

ii<br />

Private <strong>in</strong>surers had based <strong>the</strong>ir premium calculations on average life expectancy, fail<strong>in</strong>g to account for <strong>the</strong> longer<br />

than average life expectancy enjoyed by substitutive VHI policy holders, who tend to come from higher socioeconomic<br />

groups (Mossialos <strong>and</strong> Thomson 2002).<br />

iii<br />

From €41,400 to €45,900 per year. The contribution ceil<strong>in</strong>g <strong>and</strong> <strong>the</strong> threshold for return<strong>in</strong>g to <strong>the</strong> GKV rema<strong>in</strong> at<br />

€41,400.<br />

iv The average GKV contribution rate has also <strong>in</strong>creased over time, ris<strong>in</strong>g from 10.5 per cent <strong>of</strong> gross earn<strong>in</strong>gs <strong>in</strong><br />

1975 to 12.3 per cent <strong>in</strong> 1991, 13.6 per cent <strong>in</strong> 2000 <strong>and</strong> 14 per cent <strong>in</strong> 2002 (Busse 2002).<br />

v The average fee charged is €188 per person covered (exclud<strong>in</strong>g children covered as dependants) (den Exter<br />

2002).<br />

vi<br />

The WTZ now covers o<strong>the</strong>r groups, such as students whose parents are members <strong>of</strong> <strong>the</strong> ZFW.<br />

29


vii<br />

Changes to <strong>the</strong> <strong>in</strong>come threshold took place <strong>in</strong> 1994 (<strong>the</strong> van Otterloo Act), 1997 (an amendment to <strong>the</strong> Sickness<br />

Funds Act), 1998 (<strong>the</strong> <strong>Health</strong> <strong>Insurance</strong> (Restructur<strong>in</strong>g) Act) <strong>and</strong> 2000 (den Exter 2002).<br />

30

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!